Dirk K. Wolter: Sucht im Alter – Altern und Sucht

Literatur – Vervollst�ndigung

Abdullah AS, Ho LM, Kwan YH, Cheung WL, McGhee SM, Chan WH (2006): Promotingsmoking cessation among the elderly: what are the predictors of intention to quit andsuccessful quitting? J Aging Health 18(4): 552–564.

Abdullah AS, Lam TH, Chan SK, Leung GM, Chi I, Ho WW, Chan SS (2008): Effectivenessof a mobile smoking cessation service in reaching elderly smokers and predictors ofquitting. BMC Geriatr 8: 25. DOI: 101186/1471–2318–8-25.

Abraham AG, Condon NG, West Gower E (2006): The new epidemiology of cataract.Ophthalmol Clin North Am 19(4): 415–425.

Ackermann A (2006): Pr�vention. In: Oswald WD, Lehr U, Sieber C, Kornhuber J (Hrsg.):Gerontologie. Medizinische, psychologische und sozialwissenschaftliche Grundbegriffe.Stuttgart: Kohlhammer. 3. Aufl. S. 285–290.

Adams EH, Breiner S, Cicero TJ, Geller A, Inciardi JA, Schnoll SH, Senay EC, Woody GE(2006): A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone inpatients with chronic pain. J Pain Symptom Manage 31(5): 465–476.

Adams WL, Magruder-Habib K, Trued S, Broome HL (1992): Alcohol abuse in elderlyemergency department patients. J Am Geriatr Soc 40: 1236–1240.

Addolorato G, Leggio L, Abenavoli L, Agabio R, Caputo F, Capristo E, Colombo G, GessaGL, Gasbarrini G (2006): Baclofen in the treatment of alcohol withdrawal syndrome: acomparative study vs diazepam. Am J Med 119(3): e13–e18.

Adler G (2005): Verhaltenstherapeutische-Einzelpsychotherapie von Depressionen im Alter(VEDIA). Stuttgart: Schattauer.

Adlkofer F (2000): Tabak. In: Uchtenhagen A, Zieglg�nsberger W (Hrsg.): Suchtmedizin.M�nchen: Urban & Fischer. S. 39–53.

Agabio R (2005): Thiamine administration in alcohol-dependent patients. Alcohol Alcohol40: 155–156.

Agarwal S, Polydefkis M, Block B, Haythornthwaite J, Raja SN (2007): Transdermalfentanyl reduces pain and improves functional activity in neuropathic pain states. PainMed 8(7): 5545–5562.

Ait-Daoud N, Lynch WJ, Penberthy JK, Breland AB, Marzani-Nissen GR, Johnson BA(2006): Treating smoking dependence in depressed alcoholics. Alcohol Res Health 29(3):213–220.

Allard J, Artero S, Ritchie K (2003): Consumption of psychotropic medication in theelderly: a re-evaluation of its effect on cognitive performance. Int J Geriatr Psychiatry18(10): 874–878.

Allen SC (2008): What determines the ability to stop smoking in old age? Age Ageing 37(5):490–491.

Allen SS, Hatsukami D, Brintnell DM, Bade T (2005): Effect of nicotine replacementtherapy on post-cessation weight gain and nutrient intake: a randomized controlled trialof postmenopausal female smokers. Addict Behav 30(7): 1273–1280.

Almeida OP, Pfaff JJ (2005): Depression and smoking amongst older general practicepatients. J Affect Disord 86(2–3): 317–321.

Amato L, Minozzi S, Pani PP, Davoli M (2007): Antipsychotic medications for cocainedependence. Cochrane Database Syst Rev (3):CD006306.

1 © 2

010

W. K

ohlh

amm

er, S

tuttg

art

American Medical Association (Council on Scientific Affairs) (1996): Alcoholism in theElderly. JAMA 275: 797–801.

Ammon HPT (2001): Arzneimittelneben- und Wechselwirkungen. Stuttgart: Wissenschaft-liche Verlagsgesellschaft. 4. Aufl.

Anderson TL, Levy JA (2003): Marginality among older injectors in today’s illicit drugculture: assessing the impact of ageing. Addiction 98(6): 761–770.

Andreas A, Batra A, Behr J, Berck H, Chenot JF, Gillissen A, Hering T, Herth F, Meier-j�rgen R, M�hlig S, Nowak D, Pfeifer M, Raupach T, Schultz K, Sitter H, Worth H(2008): Tabakentwçhnung bei COPD (AWMF-Leitlinie). Pneumologie 62: 255–272(http://www.awmf-leitlinien.de/unter „Pneumologie“).

Andreas S, Hering T, M�hlig S, Nowak D, Raupach T, Worth H (2009): Tabakentwçhnungbei chronisch obstruktiver Lungenerkrankung. Dtsch Arztebl Int 106(16): 276–282.

Andrews JO, Heath J, Graham-Garcia J (2004): Management of tobacco dependence inolder adults: using evidence-based strategies. J Gerontol Nurs 30(12): 13–24.

Anttila T, Helkala E-L, Viitanen M, Kareholt I, Fratiglioni L, Winblad B, Soininen H,Tuomilehto J, Nissinen A, Kivipelto M (2004): Alcohol drinking in middle age andsubsequent risk of mild cognitive impairment and dementia in old age: a prospectivepopulation based study. BMJ 329: 539–542.

APA – American Psychiatric Association (2010): DSM-5 Proposed Revisions Include NewCategory of Addiction and Related Disorders. New Category of Behavioral AddictionsAlso Proposed. http://www.dsm5.org/Newsroom/Documents/Addiction%20release%2-0FINAL%202.05.pdf – Zugriff 30. 04. 2010.

Apelt S, Schmauss C, Emrich HM (1992): Psychopharmakologie und Klinik der Benzodia-zepin-Abh�ngigkeit. Fortschr Neurol Psychiat 60: 104–109.

Arndt S, Gunter TD, Acion L (2005): Older admissions to substance abuse treatment in2001. Am J Geriatr Psychiatry 13(5): 385–392.

Ashton H (1987): Benzodiazepine Withdrawal: Outcome in 50 Patients. Br J Addict 82:665–671.

Ashton H (1991): Protracted withdrawal syndromes from benzodiazepines. J Subst AbuseTreat 8: 19–28.

Ashton H (2005): The diagnosis and management of benzodiazepine dependence. CurrOpin Psychiatry 18(3): 249–255.

Augst G (1998): Wortfamilienwçrterbuch der deutschen Gegenwartssprache. T�bingen:Niemeyer.

Aveyard P, Johnson C, Fillingham S, Parsons A, Murphy M (2008): Nortriptyline plusnicotine replacement versus placebo plus nicotine replacement for smoking cessation:pragmatic randomised controlled trial. BMJ 336(7655): 1223–1237.

Ayalon L, Gum AM, Feliciano L, Are�n PA (2006): Effectiveness of nonpharmacologicalinterventions for the management of neuropsychiatric symptoms in patients with demen-tia: a systematic review. Arch Intern Med 166(20): 2182–2188.

Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gr�goire JP, Morin CM (2003):Discontinuation of benzodiazepines among older insomniac adults treated with cogni-tive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ169(10): 1015–1020.

Baillie AJ, Mattick RP (1996): The Benzodiazepine Questionnaire: Development, Reliabi-lity and Validity. Br J Psychiatry 169: 276–281.

B�K (2010): Richtlinien der Bundes�rztekammer zur Durchf�hrung der substitutions-gest�tzten Behandlung Opiatabh�ngiger vom 19. 02. 2010. http://www.bundesaerzte-kammer.de/page.asp?his=3.71.796280728073 – Zugriff 30. 04. 2010.

2

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Bakken K, Landheim AS, Vaglum P (2003): Primary and secondary substance misusers: dothey differ in substance-induced and substance-independent mental disorders? AlcoholAlcohol 38(1): 54–59.

Balfour DJK (2005): Biologische Aspekte des Rauchens. In: Batra A (Hrsg.): Tabakabh�n-gigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart: Kohlhammer.S. 42–52.

Ballantyne JC (2006): Opioids for chronic nonterminal pain. South Med J 99(11):1245–1255.

Barker MJ, Greenwood K, Jackson M, Crowe SF (2004b): Persistence of cognitive effectsafter withdrawal from long-term benzodiazepine-use: a meta-analysis. Arch Clin Neuro-psychology 19: 437–454.

Barker MJ, Greenwood K, Jackson M, Crowe SF (2005): An evaluation of persistingcognitive effects after withdrawal from long-term benzodiazepine use. J Int Neuropsy-chol Soc 11(3): 281–289.

Barnas C, Miller C, Ehrmann H, Schett P, Gunther V, Fleichhacker WW (1990): Highversus low-dose piracetam in alcoholic organic mental disorder. Psychopharmacology100: 361–365.

Barnas C, Whitworth AB, Fleischhacker WW (1993): Are Patterns of Benzodiazepine UsePredictable? A Follow-Up-Study of Benzodiazepine Users. Psychopharmacol 111:301–305.

Barrick C, Connors GJ (2002): Relapse prevention and maintaining abstinence in olderadults with alcohol-use disorders. Drugs Aging 19(8): 583–594.

Bartels SJ, Blow FC, Brockmann LM, Van Citters AD (2005): Substance Abuse and MentalHealth Among Older Americans: The State of the Knowledge and Future Directions.Rockville, MD: Older American Substance Abuse and Mental Health Technical Assis-tance Center, Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/OlderAdultsTAC/SA_MH_%20AmongOlderAdultsfinal102105.pdf –Zugriff 30. 04. 2010.

Bartzokis G, Beckson M, Hance DB, Lu PH, Foster JA, Mintz J, Ling W, Bridge P (1999):Magnetic resonance imaging evidence of „silent“ cerebrovascular toxicity in cocainedependence. Biol Psychiatry 45(9): 1203–1211.

Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Wiseman E, Bridge P (2000):Age-related brain volume reductions in amphetamine and cocaine addicts and normalcontrols: implications for addiction research. Psychiatry Res 98(2): 93–102.

Bartzokis G, Beckson M, Lu PH, Edwards N, Bridge P, Mintz J (2002): Brain maturationmay be arrested in chronic cocaine addicts. Biol Psychiatry 51(8): 605–611.

Bartzokis G, Beckson M, Lu PH, Edwards N, Rapoport R, Bridge P, Mintz J (2004):Cortical gray matter volumes are associated with subjective responses to cocaine infusi-on. Am J Addict 13(1): 64–73.

Basu R, Dodge H, Stoehr GP, Ganguli M (2003): Sedative-hypnotic use of diphenhydraminin a rural, older adult, community-based cohort. Am J Geriatr Psychiatry 11: 205–213.

Batra A (2009): Rauchen – Krankheit oder Lifestyle? Dtsch Arztebl Int 106(27): 449–450.Batra A, Buchkremer G (2004): Tabakentwçhnung. Ein Leitfaden f�r Therapeuten. Stutt-

gart: Kohlhammer.Batra A, Buchkremer G (Hrsg.) (2008): Nichtrauchen! Erfolgreich aussteigen in sechs

Schritten. Stuttgart: Kohlhammer. 2. Aufl.Batra A, Rieß O (2005): Auf der Suche nach dem „Tabakgen“ – existiert eine genetische

Grundlage des Rauchens? In: Batra A (Hrsg.): Tabakabh�ngigkeit. WissenschaftlicheGrundlagen und Behandlung. Stuttgart: Kohlhammer. S. 53–63.

3

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Batty GM, Oborne CA, Swift CG, Jackson SHD (2000): Development of an indicator toidentify inappropriate use of benzodiazepines in elderly medical inpatients. Int J GeriatrPsychiatry 15: 892–896.

B�urle P, Radebold H, Hirsch RD, Studer K, Schmid-Furstoss U, Struwe B (Hrsg.) (2000):Klinische Psychotherapie mit �lteren Menschen. Bern: Huber.

B�urle P, Fçrstl H, Hell D, Radebold H, Riedel I, Studer K (Hrsg.) (2005): Spiritualit�t undKreativit�t in der Psychotherapie mit �lteren Menschen. Bern: Huber.

Bava S, Frank LR, McQueeny T, Schweinsburg BC, Schweinsburg AD, Tapert SF (2009):Altered white matter microstructure in adolescent substance users. Psychiatry Res173(3): 228–237.

Beatty WW, Tivis R, Stott HD, Nixon SJ, Parsons OA (2000): Neuropsychological deficitsin sober alcoholics: influences of chronicity and recent alcohol consumption. AlcoholClin Exp Res 24: 149–154.

Beaudreau SA, Spira AP, Gray HL, Depp CA, Long J, Rothkopf M, Gallagher-Thompson D(2008): The relationship between objectively measured sleep disturbance and dementiafamily caregiver distress and burden. J Geriatr Psychiatry Neurol 21(3): 159–165.

Becerra L, Harter K, Gonzalez RG, Borsook D (2006): Functional magnetic resonanceimaging measures of the effects of morphine on central nervous system circuitry inopioid-naive healthy volunteers. Anesth Analg 103(1): 208–216.

B�langer L, Morin CM, Bastien C, Ladouceur R (2005): Self-efficacy and compliance withbenzodiazepine taper in older adults with chronic insomnia. Health Psychol 24 (3):281–287.

Bell CM, Fischer HD, Gill SS, Zagorski B, Sykora K, Wodchis WP, Herrmann N, BronskillSE, Lee PE, Anderson GM, Rochon PA (2007): Initiation of benzodiazepines in theelderly after hospitalization. J Gen Intern Med 22(7): 1024–1029.

Belleville G, Guay C, Guay B, Morin CM (2007): Hypnotic taper with or without self-helptreatment of insomnia: a randomized clinical trial. J Consult Clin Psychol 75(2):325–335.

Benkert O, Hippius H, Wetzel H, Gr�nder G (1996): Psychiatrische Pharmakotherapie.Berlin: Springer. 6. Aufl.

Beracochea D (2006): Anterograde and retrograde effects of benzodiazepines on memory.Scientific World Journal 16(6): 1460–1465.

Bergener M, Hampel H, Mçller HJ, Zaudig M (Hrsg.) (2005): Gerontopsychiatrie. Stutt-gart: Wissenschaftl. Verlagsgesellschaft.

Berger T (2000): Nervensystem. In: Zernig G, Saria A, Kurz M, O’Malley SS (Hrsg.):Handbuch Alkoholismus. Universit�tsklinik f�r Psychiatrie Innsbruck. S. 205–214.

Berggren U, Berglund K, Fahlke C, Aronsson E, Eriksson M, Balldin J (2007): Tobacco useis associated with more severe alcohol dependence, as assessed by the number of DSM-IVcriteria, in Swedish male type 1 alcoholics. Alcohol Alcohol 42(3): 247–251.

Berndt S, Maier C, Sch�tz H-W (1993): Polymedication and medication in patients withchronic non malignant pain. Pain 52: 331–339.

Berner MM, Kriston L, Bentele M, H�rter M (2007): The Alcohol Use Disorders Identifi-cation Test for Detecting At-Risk Drinking: A Systematic Review and Meta-Analysis.J Stud Alcohol Drugs 68(3): 461–473.

Bertz RJ, Kroboth PD, Kroboth FJ, Reynolds IJ, Salek F, Wright CE, Smith RB (1997):Alprazolam in young and elderly men: sensitivity and tolerance to psychomotor, sedativeand memory effects. J Pharmacol Exp Ther 281(3): 1317–1329.

Berzewski H (1986): Risiken und Komplikationen bei der Behandlung des alten Menschenmit Benzodiazepinen. In: H Hippius, RR Engel, G Laakmann (Hrsg.): Benzodiazepine.R�ckblick und Ausblick. Berlin: Springer. S. 121–130.

4

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Beske F (2010): Bedarfsgerechte Gesundheitsversorgung bei begrenzten Mitteln. Situations-analyse, internationaler Vergleich, Handlungsoptionen. Kiel: Institut f�r Gesundheits-System-Forschung.

Beynon CM, McVeigh J, Roe B (2007): Problematic drug use, ageing and older people:trends in the age of drug users in northwest England. Ageing Soc 27: 799–810.

Beynon CM, McVeigh J, Hurst A, Marr A (2010): Older and sicker: Changing mortality ofdrug users in treatment in the North West of England. International Journal of DrugPolicy. DOI: 101016/j.drugpo.2010. 01. 012.

Bierman EJM, Comijs HC, Gundy CM, Sonnenberg C, Jonker C, Beekman ATF (2007):The effects of chronic benzodiazepine use on cognitive functioning in older persons:good, bad or indifferent? Int J Geriatr Psychiatry 22: 1194–1200.

Bilitza KW (Hrsg.) (2009c): Psychodynamik der Sucht. Psychoanalytische Beitr�ge zurTheorie. Gçttingen: Vandenhoeck & Ruprecht. 2. Aufl.

Bilitza KW (Hrsg.) (2009d): Psychotherapie der Sucht. Psychoanalytische Beitr�ge zurPraxis. Gçttingen: Vandenhoeck & Ruprecht. 2. Aufl.

Bize R, Burnand B, Mueller Y, Cornuz J (2007): Effectiveness of biomedical risk assessmentas an aid for smoking cessation: a systematic review. Tob Control 16(3): 151–156.

Bize R, Burnand B, Mueller Y, R�ge Walther M, Cornuz J (2009): Biomedical risk assess-ment as an aid for smoking cessation (Review). Cochrane Database Syst Rev Issue 2. Art.No.: CD004705. DOI: 101002/14651858.CD004705.pub3.

Bjartveit K, Tverdal A (2005): Health consequences of smoking 1–4 cigarettes per day. TobControl 14(5): 315–320.

Bjartveit K, Tverdal A (2009): Health consequences of sustained smoking cessation. TobControl 18(3): 197–205.

Blazer DG, Wu LT (2009a): The Epidemiology of At-Risk and Binge Drinking AmongMiddle-Aged and Elderly Community Adults: National Survey on Drug Use and Health.Am J Psychiatry 166: 1162–1169.

Blazer DG, Wu LT (2009b): The epidemiology of substance use and disorders amongmiddle aged and elderly community adults: national survey on drug use and health.Am J Geriatr Psychiatry 17(3): 237–245.

Bleich S, Bandelow B, Javaheripour K, M�ller A, Degner D, Wilhelm J, Havemann-Rein-ecke U, Sperling W, R�ther E, Kornhuber J (2003a): Hyperhomocysteinemia as a newrisk factor for brain shrinkage in patients with alcoholism. Neurosci Lett 335: 179–182.

Bleich S, Sperling W, Wiltfang J, Maler JM, Kornhuber J (2003b): Exzitatorische Neuro-transmission bei chronischem Alkoholismus. Fortschr Neurol Psychiat 71 (Suppl):S36–S44.

Blow FC, Brockmann LM, Barry KL (2004): Role of alcohol in late-life suicide. AlcoholClin Exp Res 28(5 Suppl): 48S–56S.

BMFSFJ – Bundesministerium f�r Familie, Senioren, Frauen und Jugend (1988): Empfeh-lungen der Expertenkommission der Bundesregierung zur Reform der Versorgung impsychiatrischen und psychotherapeutisch/psychosomatischen Bereich. Bonn.

BMFSFJ – Bundesministerium f�r Familie, Senioren, Frauen und Jugend (2002): VierterBericht zur Lage der �lteren Generation in der Bundesrepublik Deutschland. Risiken,Lebensqualit�t und Versorgung Hochaltriger – unter besonderer Ber�cksichtigungdementieller Erkrankungen. Bonn.

Boddiger D (2008): Drug abuse in older US adults worries experts. Lancet 372(9650):1622.

Bond GE, Burr RL, McCurry SM, Rice MM, Borenstein AR, Larson EB (2005): Alcoholand cognitive performance: a longitudinal study of older Japanese Americans. The KameProject. Int Psychogeriatr 17: 653–668.

5

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Bonnet U, Gastpar M (1999): Opioide. In: Gastpar M, Mann K, Rommelspacher H(Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 237–262.

Bonnet U, Banger M, Leweke FM, Specka M, M�ller BW, Hashemi T, Nyhuis PW, Kut-scher S, Burtscheidt W, Gastpar M (2003): Treatment of acute alcohol withdrawal withgabapentin: results from a controlled two-center trial. J Clin Psychopharmacol 23(5):514–519.

Bçning J, Schrappe O (1984): Benzodiazepin-Abh�ngigkeit: Klinik der Entzugssyndrome.Dtsch �rztebl 81: 279–285.

Borscheid P (1994): Der alte Mensch in der Vergangenheit. In: Baltes PB, Mittelstraß J,Staudinger UM (Hrsg.): Alter und Altern. Ein interdisziplin�rer Studientext zur Geron-tologie. Berlin: de Gruyter. S. 35–61.

Borucki K, Schreiner R, Dierkes J, Jachau K, Krause D, Westphal S, Wurst FM, Luley C,Schmidt-Gayk H (2005): Detection of Recent Ethanol Intake With New Markers: Com-parison of Fatty Acid Ethyl Esters in Serum and of Ethyl Glucuronide and the Ratio of5-Hydroxytryptophol to 5-Hydroxyindole Acetic Acid in Urine. Alcohol Clin Exp Res29: 781–787.

Botella-Carretero JI, Escobar-Morreale HF, Mart�n I, Valero AM, Alvarez F, Garc�a G,Varela C, Cantarero M (2004): Weight gain and cardiovascular risk factors duringsmoking cessation with bupropion or nicotine. Horm Metab Res 36(3): 178–182.

Bowden SC (1990): Separating cognitive impairment in neurologically asymptomatic alco-holics from Wernicke-Korsakoff syndrome: is the neuropsychological distinction justi-fied? Psychol Bull 107: 355–366.

Boyle RG, Solberg LI, Magnan S, Davidson G, Alesci NL. (2002): Does insurance coveragefor drug therapy affect smoking cessation? Health Affairs 21(6): 162.

Bradley KA, DeBenedetti AF, Volk RJ, Williams EC, Frank D, Kivlahan DR (2007):AUDIT-C as a brief screen for alcohol misuse in primary care. Alcohol Clin Exp Res31(7): 1208–1217.

Bramness JG, Skurtveit S, Mørland J (2006): Flunitrazepam: psychomotor impairment,agitation and paradoxical reactions. Forensic Sci Int 159(2–3): 83–91.

Brandenberg C, Nehen HG (2010): Die Belastung pflegender Angehçriger, eine Vergleichs-untersuchung in den Jahren 1998 und 2007. (In Vorbereitung)

Brands B, Blake J, Marsh DC, Sproule B, Jeyapalan R, Li S (2008): The impact of ben-zodiazepine use on methadone maintenance treatment outcomes. J Addict Dis 27(3):37–48.

Brandtst�dter J, Lindenberger U (Hrsg.) (2007): Entwicklungspsychologie der Lebensspan-ne. Ein Lehrbuch. Stuttgart: Kohlhammer.

Brega AG, Grigsby J, Kooken R, Hamman RF, Baxter J (2008): The impact of executivecognitive functioning on rates of smoking cessation in the San Luis Valley Health andAging Study. Age Ageing 37(5): 521–525.

Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H (2009): Aufhçrversucheund -wille bei �lteren Rauchern. Epidemiologische Beitr�ge zur Diskussion um „Life-style“ versus „Sucht“. Dtsch Arztebl Int 106(27): 451–455. DOI: 103238/arz-tebl.20090451.

Brennan PL, Nichols KA, Moos RH (2002): Long-term use of VA mental health services byolder patients with substance use disorders. Psychiatr Serv 53(7): 836–841.

Brennan PL, Schutte KK, Moos RH (2005): Pain and use of alcohol to manage pain:prevalence and 3-year outcomes among older problem and non-problem drinkers.Addiction 100(6): 777–786.

Breslau N, Johnson EO (2000): Predicting smoking cessation and major depression innicotine-dependent smokers. Am J Public Health 90(7): 1122–1127.

6

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Brinker A, Beitz RABJ, Yates WR (2002): Abuse, dependence, or withdrawal associatedwith tramadol/Dr. Yates replies. Am J Psychiatry 159(5): 881.

Brokate B, Hildebrandt H, Elling P, Fichtner H, Runge K, Timm C (2003): Frontal lobedysfunctions in Korsakoff’s syndrome and chronic alcoholism: continuity or discontinui-ty? Neuropsychology 17: 420–428.

Brower KJ, Mudd S, Blow FC, Young JP, Hill EM (1994): Severity and treatment of alcoholwithdrawal in elderly versus younger patients. Alcohol Clin Exp Res 18(1): 196–201.

Brown DW, Croft JB, Schenck AP, Malarcher AM, Giles WH, Simpson RJ Jr (2004):Inpatient smoking-cessation counseling and all-cause mortality among the elderly. AmJ Prev Med 26(2): 112–118.

Brown RT, Zuelsdorff M, Fleming M (2006): Adverse effects and cognitive function amongprimary care patients taking opioids for chronic nonmalignant pain. J Opioid Manag2(3): 137–146.

Bruder J (1989): Suchtmittelgebrauch und Suchtmittelmissbrauch im Alter aus gerontolo-gischer Sicht. In: Abh�ngigkeit im Alter. Mçglichkeiten und Grenzen der Hilfe. Ham-burg: Hamburgische Landesstelle gegen die Suchtgefahren. S. 7–16.

Brun A, Andersson J (2001): Frontal dysfunction and frontal cortical synapse loss inalcoholism – the main cause of alcohol dementia? Dement Geriatr Cogn Disord 12:289–294.

B�chner U (2009): Der R�ckfall im diagnostischen und therapeutischen Prozess. In: BilitzaKW (Hrsg.): Psychotherapie der Sucht. Psychoanalytische Beitr�ge zur Praxis. Gçttingen:Vandenhoeck & Ruprecht. 2. Aufl. S. 179–190.

Buffett-Jerrott SE, Stewart SH, Bird S, Teehan MD (1998): An examination of differencesin the time course of oxazepam’s effects on implicit vs explicit memory. J Psychophar-macol 12(4): 338–347.

B�hringer G, Augustin R, Bergmann E, Bloomfield K, Funk W, Junge B, Kraus L, Merfert-Diete C, Rumpf HJ, Simon R, Tçppich J (2000): Alkoholkonsum und AlkoholbezogeneStçrungen in Deutschland. Schriftenreihe des BMG, Band 128. Baden-Baden: Nomos.

B�hringer P (2010): Priorisierung in Psychiatrie und Psychotherapie. Gegen heimlicheRationierungen. Dtsch Arztebl 107(6): A-226/B-205/C-201.

Burnette MM, Meilahn E, Wing RR, Kuller LH (1998): Smoking cessation, weight gain,and changes in cardiovascular risk factors during menopause: the Healthy Women Study.Am J Public Health 88(1): 93–96.

Burns A (2004): Psychological and behavioural interventions in dementia. Curr Opin Psy-chiatry 17: 433–437.

Burns DM (2003a): Epidemiology of smoking-induced cardiovascular disease. Prog Car-diovasc Dis 46(1): 11–29.

Burns DM (2003b): Tobacco-related diseases. Semin Oncol Nurs 19(4): 244–249.Burns DM (2008): Live Fast, Die Young, Leave a Good-looking Corpse. Arch Intern Med

1946–1947.Busto UE, Sykora K, Sellers EM (1989): A clinical scale to assess benzodiazepine with-

drawal. J Clin Psychopharmacol 9(6): 412–416.Bø K, Thoresen M, Dalgard F (2008): Smokers report more psoriasis, but not atopic

dermatitis or hand eczema: results from a Norwegian population survey among adults.Dermatology 216(1): 40–45.

Cahill K, Perera R (2008): Competitions and incentives for smoking cessation. CochraneDatabase Syst Rev Issue 3. Art. No.: CD004307. DOI: 101002/14651858.CD00-4307.pub3.

7

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Cahill K, Stead LF, Lancaster T (2008): Nicotine receptor partial agonists for smokingcessation. Cochrane Database Syst Rev Issue 3. Art. No.: CD006103. DOI:01002/14651858.CD006103.pub3.

Caldarone BJ, King SL, Picciotto MR (2008): Sex differences in anxiety-like behavior andlocomotor activity following chronic nicotine exposure in mice. Neurosci Lett 439(2):187–191.

Cantopher T, Olivieri S, Cleave N, Edwards JG (1990): Chronic benzodiazepine depen-dence. A comparatative study of abrupt withdrawal under propranolol cover versusgradual withdrawal. Br J Psychiatry 156: 406–411.

Cargill BR, Emmons KM, Kahler CW, Brown RA (2001): Relationship among alcohol use,depression, smoking behavior, and motivation to quit smoking with hospitalized smo-kers. Psychol Addict Behav 15(3): 272–275.

Carlen PL, McAndrews MP, Weiss RT, Dongier M, Hill JM, Menzano E, Farcnick K,Abarbanel J, Eastwood MR (1994): Alcohol-related dementia in the institutionalizedelderly. Alcohol Clin Exp Res 18: 1330–1334.

Carlsten A, Waern M (2009): Are sedatives and hypnotics associated with increased suiciderisk of suicide in the elderly? BMC Geriatr 4(9): 20.

Chaney SE, Sheriff S (2008): Weight gain among women during smoking cessation: testingthe effects of a multifaceted program. AAOHN J 56(3): 99–105.

Chang L, Chronicle EP (2007): Functional imaging studies in cannabis users. Neuroscien-tist 13(5): 422–432.

Chen CY, Lin KM (2009): Health consequences of illegal drug use. Curr Opin Psychiatry22(3): 287–292.

Chen Y, Horne SL, Dosman JA (1993): The influence of smoking cessation on body weightmay be temporary. American Journal of Public Health 83(9): 1330–1332.

Chinn S, Jarvis D, Melotti R, Luczynska C, Ackermann-Liebrich U, Ant JM, Cerveri I, deMarco R, Gislason T, Heinrich J, Janson C, K�nzli N, Leynaert B, Neukirch F, SchoutenJ, Sunyer J, Svanes C, Vermeire P, Wjst M, Burney P (2005): Smoking cessation, lungfunction, and weight gain: a follow-up study. Lancet 365(9471): 1629–1635.

Chiolero A, Faeh D, Paccaud F, Cornuz J (2008): Consequences of smoking for bodyweight, body fat distribution, and insulin resistance. Am J Clin Nutr 87(4): 801–809.

Christo PJ, Grabow TS, Raja SN (2004): Opioid effectiveness, addiction, and depression inchronic pain. Adv Psychosom Med 25: 123–137.

Clark MA, Rakowski W, Kviz FJ, Hogan JW (1997): Age and stage of readiness forsmoking cessation. J Gerontol B Psychol Sci Soc Sci 52(4): S212–S221.

Clarke PR, Eccersley PS, Frisby JP, Thornton JA (1970): The amnesic effect of diazepam(Valium). Br J Anaest 42(8): 690–697.

Clipp EC, George LK (1990): Psychotropic Drug Use Among Caregivers of Patients WithDementia. J Am Geriatr Soc 38: 227–235.

Closs C, Lal A (1990): Suchtkrankenhilfe f�r alte Menschen in Heimen und Krankenh�u-sern. In: Alter und Sucht. Hamburg: Hamburgische Landesstelle gegen die Suchtgefah-ren. S. 53–58.

Cochrane M, Cochrane A, Jauhar P, Ashton E (2005): Acetylcholinesterase inhibitors forthe treatment of Wernicke-Korsakoff syndrome – three further cases show response todonepezil. Alcohol Alcohol 40: 151–154.

Cole JO, Kando JC (1993): Adverse behavioral events reported in patients taking alprazo-lam and other benzodiazepines. J Clin Psychiatry 54 (Suppl): 49–61.

Collins N, Sachs-Ericsson N, Preacher KJ, Sheffield KM, Markides K (2009): SmokingIncreases Risk for Cognitive Decline Among Community-Dwelling Older Mexican Ame-ricans. Am J Geriatr Psychiatry 17: 934–942.

8

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Colliver JD, Compton WM, Gfroerer JC, Condon T (2006): Projecting drug use amongaging baby boomers in 2020. Ann Epidemiol 16(4): 257–265.

Colzato LS, Huizinga M, Hommel B (2009a): Recreational cocaine polydrug use impairscognitive flexibility but not working memory. Psychopharmacology 207(2): 225–234.

Colzato LS, van den Wildenberg WP, Hommel B (2009b): Reduced attentional scope incocaine polydrug users. PLoS One 4(6): e6043.

Cook JM, Marshall R, Masci C, Coyne JC (2007): Physicians’ perspectives on prescribingbenzodiazepines for older adults: a qualitative study. J Gen Intern Med 22(3): 303–307

Coper H (2000): Stimulanzien. In: Uchtenhagen A, Zieglg�nsberger W (Hrsg.): Suchtmedi-zin. M�nchen: Urban & Fischer. S. 71–77.

Couv�e JA (2002): Towards a treatment of chronic benzodiazepine users suffering fromdepression. Kumulative Dissertation Universit�t Leiden.

Couv�e JE, Zitman FG (2002): The benzodiazepine withdrawal symptom questionnaire:psychometric evaluation during a discontinuation program in depressed chronic ben-zodiazepine users in general practice. Addiction 97: 337–345 (auch in: Couv�e JA:Towards a treatment of chronic benzodiazepine users suffering from depression. Disser-tation Universit�t Leiden. S. 47–58).

Crews FT, Collins MA, Dlugos C, Littleton J, Willkins L, Neafsey EJ, Pentney R, Snell LD,Tabakoff B, Noronha A (2004): Alcohol-induced neurodegeneration: when, where why?Alcohol Clin Exp Res 28: 350–364.

Crews FT, Buckley T, Dodd PR, Ende G, Foley N, Harper C, He J, Innes D, Loh EW,Pfefferbaum A, Zou J, Sullivan EV (2005): Alcoholic neurobiology: changes in depen-dence and recovery. Alcohol Clin Exp Res 29: 1504–1513.

Crews FT, He J, Hodge C (2007): Adolescent cortical development: a critical period ofvulnerability for addiction. Pharmacol Biochem Behav 86(2): 189–199.

Crews FT, Boettiger CA (2009): Impulsivity, frontal lobes and risk for addiction. PharmacolBiochem Behav 93: 237–247.

Crews FT, Nixon K (2003): Alcohol, neural stem cells, and adult neurogenesis. Alcohol ResHealth 27: 197–204.

Critchley JA, Capewell S (2003): Mortality risk reduction associated with smoking cessa-tion in patients with coronary heart disease: a systematic review. JAMA 290(1): 86–97.

Crome I, Sidhu H, Crome P (2009): No longer only a young man’s disease – illicit drugsand older people. J Nutr Health Aging 13(2): 141–143.

Curtis JR, Geller G, Stokers EJ, Levine DM, Moore RD (1989): Characteristics, diagnosis,and treatment of alcoholism in elderly patients. J AM GERIATR SOC 37: 310–316.

Cysique LA, Brew BJ (2009): Neuropsychological functioning and antiretroviral treatmentin HIV/AIDS: a review. Neuropsychol Rev 19(2): 169–185.

David SP, Munaf MR (2008): Smoking cessation in primary care. Evidence does notsupport routine use of combination therapy with nortriptyline. BMJ 336: 1200–1201.

Davies SJ, Pandit SA, Feeney A, Stevenson BJ, Kerwin RW, Nutt DJ, Marshall EJ, Bod-dington S, Lingford-Hughes A (2005): Is there cognitive impairment in clinically „heal-thy“ abstinent alcohol dependence? Alcohol Alcohol 40: 498–503.

Day E, Bentham P, Callaghan R, Kuruvilla T, George S (2009): Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst RevDII: 101002/14651858.CD004033.pub2.

Deary IJ, Pattie A, Taylor MD, Whiteman MC, Starr JM, Whalley LJ (2003): Smoking andcognitive change from age 11 to age 80. Journal of Neurology, Neurosurgery, and Psy-chiatry 74: 1006–1007.

Degenhardt L, Lynskey M, Hall W (2000): Cohort trends in the age of initiation of drug usein Australia. Aust N Z J Public Health 24(4): 421–426.

9

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

de las Cuevas C, Sanz EJ, de la Fuente JA et al. (2000): The severity of dependence scale(SDS) as screening test for benzodiazepine dependence: SDS Validation study. Addiction95: 245–250.

Denis C, Fats�as M, Lavie E, Auriacombe M (2006): Pharmacological interventions forbenzodiazepine mono-dependence management in outpatient settings. Cochrane Data-base Syst Rev Issue 3. Art. No.: CD005194. DOI: 101002/14651858.CD005194.pub2.

Des Jarlais DC, Arasteh K, Perlis T, Hagan H, Heckathorn DD, Mcknight C, Bramson H,Friedman SR (2007): The transition from injection to non-injection drug use: long-termoutcomes among heroin and cocaine users in New York City. Addiction 102(5):778–785.

Deng J, Zhou DH, Li J, Wang YJ, Gao C, Chen M (2006): A 2-year follow-up study ofalcohol consumption and risk of dementia. Clin Neurol Neurosurg 108: 378–383.

De Oliveira LG, Barroso LP, Silveira CM, Sanchez ZV, De Carvalho Ponce J, Vaz LJ,Nappo SA (2009): Neuropsychological assessment of current and past crack cocaineusers. Subst Use Misuse 44(13): 1941–1957.

Donny EC, Houtsmuller E, Stitzer ML (2006): Smoking in the absence of nicotine: beha-vioral, subjective and physiological effects over 11 days. Addiction 102: 324–334.

Donny EC, Dierker LC (2007): The absence of DSM-IV nicotine dependence in moderate-to-heavy daily smokers. Drug Alcohol Depend 89(1): 93–96.

Donz� J, Ruffieux C, Cornuz J (2007): Determinants of smoking and cessation in olderwomen. Age Ageing 36(1): 53–57.

Doolan DM, Froelicher ES (2006): Efficacy of smoking cessation intervention amongspecial populations: review of the literature from 2000 to 2005. Nurs Res 55(4 Suppl):S29–S37.

Doolan DM, Stotts NA, Benowitz NL, Covinsky KE, Froelicher ES (2008): The Women’sInitiative for Nonsmoking (WINS) XI: age-related differences in smoking cessationresponses among women with cardiovascular disease. Am J Geriatr Cardiol 17(1):37–47.

DSM-IV (1998): Diagnostisches und statistisches Manual Psychischer Stçrungen. Hogrefe:Gçttingen. 2. Aufl.

Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW (2008): A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychia-try 165(2): 179–187.

Dworetzky BA, Bromfield EB, Townsend MK, Kang JH (2010): A prospective study ofsmoking, caffeine, and alcohol as risk factors for seizures or epilepsy in young adultwomen: data from the Nurses’ Health Study II. Epilepsia 51(2): 198–205.

Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, John U, Broocks A,Hohagen F, Rumpf HJ (2006): The reliability and validity of the Alcohol Use DisordersIdentification Test (AUDIT) in a German general practice population sample. J StudAlcohol 67(3): 473–481.

DZA – Deutsches Zentrum f�r Altersfragen (2010): Deutscher Alterssurvey: Die zweiteLebensh�lfte. http://www.dza.de/nn_39284/DE/Forschung/Alterssurvey/alterssurvey_no-de.html?_nnn=true – Zugriff 13.09.2010.

Ebly EM, Hogan DB, Fung TS (1997): Potential Adverse Outcomes of Psychotropic andNarcotic Drug Use in Canadian Seniors. J Clin Epidemiol 50: 857–863.

Edelstein SL, Kritz-Silverstein D, Barrett-Connor E (1998): Prospective association of smo-king and alcohol use with cognitive function in an elderly cohort. J Womens Health7(10): 1271–1281.

10

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M (2007): Risk factors for clinicallyrecognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 129(3): 355–362.

Egan M, Moride Y, Wolfson C, Monette J (2000): Long-term continuous use of benzodia-zepines by older adults in Quebec: prevalence, incidence and risk factors. J Am GeriatrSoc 48(7): 811–816.

Eggers C (2000): HIV-1-assoziierte Enzephalopathie und Myelopathie. Nervenarzt 71:677–684.

Eisen SA, Lyons MJ, Goldberg J, True WR (1993): The impact of cigarette and alcoholconsumption on weight and obesity. An analysis of 1911 monozygotic male twin pairs.Arch Intern Med 153(21): 2457–2463.

Eisenberg D, Quinn BC (2006): Estimating the effect of smoking cessation on weight gain:an instrumental variable approach. Health Serv Res 41(6): 2255–2266.

Elwert G (1994): Altern im interkulturellen Vergleich. In: Baltes PB, Mittelstraß J, Stau-dinger UM (Hrsg.): Alter und Altern. Ein interdisziplin�rer Studientext zur Gerontologie.Berlin: de Gruyter. S. 261–282.

Emsley R, Smith R, Roberts M, Kapnias S, Pieters H, Maritz S (1996): Magnetic resonanceimaging in alcoholic Korsakoff’s syndrome: evidence for an association with alcoholicdementia. Alcohol Alcohol 31: 479–486.

Epstein EE, Fischer-Elber K, Al-Otaiba Z (2007): Women, aging, and alcohol use disorders.J Women Aging 19(1–2): 31–48.

Epstein-Lubow G, Davis JD, Miller IW, Tremont G (2008): Persisting burden predictsdepressive symptoms in dementia caregivers. J Geriatr Psychiatry Neurol 21(3):198–203.

Ersek M, Cherrier MM, Overman SS, Irving GA (2004): The cognitive effects of opioids.Pain Manag Nurs 5(2): 75–93.

Espeland MA, Coker LH, Wallace R, Rapp SR, Resnick SM, Limacher M, Powell LH,Messina CR; Women’s Health Initiative Study of Cognitive Aging (2006): Associationbetween alcohol intake and domain-specific cognitive function in older women. Neuro-epidemiology 27: 1–12.

Estler CJ (1997): Arzneimittel im Alter. Stuttgart: Wissenschaftliche Verlagsgesellschaft.2. Aufl.

Ettrich KU, Fischer-Cyrulies A (2004): Substanzmissbrauch im mittleren und hçherenErwachsenenalter – Allgemeiner Missbrauch. Z Gerontol Geriat 37: 272–279.

Fagerstrçm KO (2005): Raucherentwçhnung – wie effektiv kann sie sein? In: Batra A(Hrsg.): Tabakabh�ngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart:Kohlhammer. S. 93–96.

Fagerstrçm K, Aubin HJ (2009): Management of smoking cessation in patients with psy-chiatric disorders. Curr Med Res Opin 25(2): 511–518.

Falck RS, Wang J, Carlson RG (2007): Crack cocaine trajectories among users in a mid-western American city. Addiction 102(9): 1421–1431.

Falck RS, Wang J, Carlson RG (2008): Among long-term crack smokers, who avoids andwho succumbs to cocaine addiction? Drug Alcohol Depend 98: 24–29.

Fama R, Marsh L, Sullivan EV (2004a): Dissociation of remote and anterograde memoryimpairment and neuronal correlates in alcoholic Korsakoff syndrome. J Int Neuropsy-chol Soc 10: 427–441.

Fama R, Pfefferbaum A, Sullivan EV (2004b): Perceptual learning in detoxified alcoholicmen: contributions from explicit memory, executive function, and age. Alcohol Clin ExpRes 28: 1657–1665.

11

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Fama R, Pfefferbaum A, Sullivan EV (2006): Visuoperceptual learning in alcoholic Korsa-koff syndrome. Alcohol Clin Exp Res 30: 680–687.

Fastbom J, Forsell Y, Winblad B (1998): Benzodiazepines may have protective effectsagainst Alzheimer disease. Alzheimer Dis Assoc Disord 12: 14–17.

Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ (2002):Cortical grey matter loss in treatment-naive alcohol dependent individuals. Alcohol ClinExp Res 26: 558–564.

Fein G, Torres J, Price LJ, Di Sclafani V (2006): Cognitive performance in long-termabstinent alcoholic individuals. Alcohol Clin Exp Res 30: 1538–1544.

Fengler J (1992): Helfende Berufe – Umgang mit Medikamenten und Medikamentenabh�n-gigen. In: Deutsche Hauptstelle gegen die Suchtgefahren (Hrsg.): Medikamentenabh�n-gigkeit. Freiburg: Lambertus. S. 202–207.

Ferguson J, Bauld L, Chesterman J, Judge K (2005): The English smoking treatment ser-vices: one-year outcomes. Addiction 100 (Suppl 2): 59–69.

Ferrara CM, Kumar M, Nicklas B, McCrone S, Goldberg AP (2001): Weight gain andadipose tissue metabolism after smoking cessation in women. Int J Obes Relat MetabDisord 25(9): 1322–1326.

Ferrara M, Langiano E, Di Brango T, De Vito E, Di Cioccio L, Bauco C (2008): Prevalenceof stress, anxiety and depression in with Alzheimer caregivers. Health Qual Life Out-comes 6(6): 93.

Filozof C, Fern�ndez Pinilla MC, Fern�ndez-Cruz A (2004): Smoking cessation and weightgain. Obes Rev 5(2): 95–103.

Finlayson RE (1995): Misuse of Prescription Drugs. Int J Addict 30: 1871–1901.Fischer T (2009): Gruppenpsychotherapie bei Abh�ngigkeitserkrankungen. In: Bilitza KW

(Hrsg.): Psychotherapie der Sucht. Psychoanalytische Beitr�ge zur Praxis. Gçttingen:Vandenhoeck & Ruprecht. 2. Aufl. S. 111–131.

Fishbain DA (2003): Chronic opioid treatment, addiction and pseudo-addiction in patientswith chronic pain. Psychiatric Times, Vol XX, Issue 2.

Fishbain DA, Rosomoff HL, Rosomoff RS (1992): Drug abuse, dependence, and addictionin chronic pain patients. Clin J Pain 8: 77–85.

Flegal KM, Troiano RP, Pamuk ER, Kuczmarski RJ, Campbell SM (1995): The influence ofsmoking cessation on the prevalence of overweight in the United States. N Engl J Med333(18): 1165–1170.

Fleischhacker WW (1995): Unerw�nschte Wirkungen, Kontraindikationen, �berdosierun-gen, Intoxikation. In: Riederer P, Laux G, Pçldinger W (Hrsg): Neuro-Psycho-Pharmaka.Bd. 2: Tranquilizer und Hypnotika. Wien: Springer. S. 84–89.

Fleischhacker WW, Barnas C, Hinterhuber H (1987): Benzodiazepin-Verordnungen aneiner Universit�tsklinik. Nervenarzt 58: 754–758.

Fleming MF, Manwell LB, Barry KL, Adams W, Stauffacher EA (1999): Brief physicianadvice for alcohol problems in older adults: a randomized community-based trial. J FamPract 48(5): 378–384.

Fçrstl H (Hrsg.) (2003): Lehrbuch der Gerontopsychiatrie- und -psychotherapie. Stuttgart:Thieme. 2. Aufl.

Fçrstl H (2006): Kognitive Stçrungen: Koma, Delir, Demenz. In: Fçrstl H, Hautzinger M,Roth G (Hrsg.): Neurobiologie psychischer Stçrungen. Heidelberg: Springer.S. 221–295.

Foy A, O’Connell D, Henry D, Kelly J, Cocking S, Halliday J (1995): Benzodiazepine Useas a Cause of Cognitive Impairment in Elderly Hospital Inpatients. J Gerontol A Biol SciMed Sci 50: M99–106.

12

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Frank C (2010): „Ordentlich Pegel“ Viele �rzte sind s�chtig nach Tabletten, Alkohol undNikotin – eine besondere Therapieform hilft den kranken Helfern. S�ddeutsche Zeitung12. 01. 2010.

Franklin KBJ (1998): Analgesia and abuse potential: an accidental association or a commonsubstrate? Pharmacology Biochemistry and Behavior 59: 993–1002.

Frei A (1996): Benzodiazepine – unn�tz und sch�dlich? (Rez. von „Benzodiazepin-Depen-dence“, ed. by Halstroem C, Oxford 1993). Psychiat Prax 23: 155–156.

Freye E (2010): Opioide in der Medizin. Heidelberg: Springer. 8. Aufl.Freye E, Levy J (2000): Acute abstinence syndrome following abrupt cessation of long-term

use of tramadol (Ultram): a case study. Eur J Pain 4(3): 307–311.Freye E, Latasch L (2003): Toleranzentwicklung unter Opioidgabe – Molekulare Mecha-

nismen und klinische Bedeutung. An�sthesiol Intensivmed Notfallmed Schmerzther38(1): 14–26.

Fritze J (2009): Versorgungsgerechtigkeit in der Lebensspanne. Nervenarzt 80(11):1283–1292.

Froom P, Melamed S, Benbassat J (1998): Smoking cessation and weight gain. J Fam Pract46(6): 460–464.

G�rtner J, Radbruch L, Giesecke T, Gerbershagen H, Petzke F, Ostgathe C, Elsner F,Sabatowski R (2006): Assessing cognition and psychomotor function under long-termtreatment with controlled release oxycodone in non-cancer pain patients. Acta Anaes-thesiol Scand 50(6): 664–672.

Gallop RJ, Crits-Christoph P, Ten Have TR, Barber JP, Frank A, Griffin ML, Thase ME(2007): Differential transitions between cocaine use and abstinence for men and women.J Consult Clin Psychol 75(1): 95–103.

Ganguli M, van der Bilt J, Saxton JA, Shen C, Dodge HH (2005): Alcohol consumption andcognitive function in late life: a longitudinal community study. Neurology 65:1210–1217.

Geiselmann B (1992): Langzeittherapie mit Psychopharmaka versus Arzneimittelabh�ngig-keit. In: Helmchen H, Linden M (Hrsg.): Die jahrelange Behandlung mit Psychophar-maka. Berlin, New York: de Gruyter. S. 185–201.

Gfroerer JC, Epstein JF (1999): Marijuana initiates and their impact on future drug abusetreatment need. Drug Alcohol Depend 54(3): 229–237.

Gfroerer JC, Penne M, Pemberton M, Folsom R (2003): Substance abuse treatment needamong older adults in 2020: the impact of the aging baby-boom cohort. Drug AlcoholDepend 69(2): 127–135.

Gilg T (2005): Rechtsmedizinische Aspekte von Alkohol und Alkoholismus. In: Singer MV,Teyssen S (Hrsg.): Alkohol und Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl.S. 551–576.

Glaeske G (1991): Arzneimittelverbrauch von Menschen im hçheren Lebensalter unterbesonderer Ber�cksichtigung von Arzneimitteln mit Abh�ngigkeitspotential. D�sseldorf:Ministerium f�r Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen.

Glassman AH, Covey LS, Stetner F, Rivelli S (2001): Smoking cessation and the course ofmajor depression: a follow-up study. Lancet 357(9272): 1929–1932.

Godtfredsen NS, Holst C, Prescott E, Vestbo J, Osler M (2002): Smoking reduction, smo-king cessation, and mortality: a 16-year follow-up of 19732 men and women from TheCopenhagen Centre for Prospective Population Studies. Am J Epidemiol 156(11):994–1001.

Godtfredsen NS, Osler M, Vestbo J, Andersen I, Prescott E (2003): Smoking reduction,smoking cessation, and incidence of fatal and non-fatal myocardial infarction in Den-

13

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

mark 1976–1998: a pooled cohort study. J Epidemiol Community Health 57(6):412–416.

Godtfredsen NS, Prescott E, Osler M (2005): Effect of smoking reduction on lung cancerrisk. JAMA 294(12): 1505–1510.

Golub A, Johnson BD, Dunlap E, Sifaneck S (2004): Projecting and Monitoring the LifeCourse of the Marijuana/Blunts Generation. J Drug Issues 34(2): 361–388.

Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, Watsky EJ, Gong J,Williams KE, Reeves KR; Varenicline Phase 3 Study Group (2006): Varenicline, analpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupro-pion and placebo for smoking cessation: a randomized controlled trial. JAMA 296(1):47–55.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, van denHoogen HJ, Mulder J, Breteler MH, Zitman FG (2005): Discontinuation of long-termbenzodiazepine use by sending a letter to users in family practice: a prospective con-trolled intervention study. Drug Alcohol Depend 78 (1): 49–56.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, van Balkom AJ, Breteler MH,van den Hoogen HJ, Mulder J, Zitman FG (2006): Predictors of discontinuation ofbenzodiazepine prescription after sending a letter to long-term benzodiazepine users infamily practice. Fam Pract 23 (1): 65–72.

Gorgels WJ, Oude Voshaar RC, Mol AJ, van de Lisdonk EH, Mulder J, van den Hoogen H,van Balkom AJ, Breteler MH, Zitman FG (2007): Consequences of a benzodiazepinediscontinuation programme in family practice on psychotropic medication prescriptionto the participants. Fam Pract 24(5): 504–510.

Gosselin P, Ladouceur R, Morin CM, Dugas MJ, Baillargeon L (2006): Benzodiazepinediscontinuation among adults with GAD: A randomized trial of cognitive-behavioraltherapy. J Consult Clin Psychol 74 (5): 908–919.

Grad R, Tamblyn R, Holbrook AM, Hurley J, Feightner J, Grayton D (1999): Risk of NewBenzodiazepine Presription in Relation to Recent Hospitalization. J Am Geriatr Soc 47:184–188.

Gr�ßel E (1998): H�usliche Pflege dementiell und nicht dementiell Erkrankter. Z GerontolGeriat 31: 57–62.

Greenblatt DJ, Harmatz JS, Shader RI (1991a): Clinical Pharmacokinetics of Anxiolyticsand Hypnotics in the Elderly. Therapeutic Considerations (Part I). Clin Pharmacokinet21: 165–177.

Greenblatt DJ, Harmatz JS, Shader RI (1991b): Clinical Pharmacokinetics of Anxiolyticsand Hypnotics in the Elderly. Therapeutic Considerations (Part II). Clin Pharmacokinet21: 262–273.

Grohmann R, Poser W, Schmidt LG, Wolf B (1991): Medikamenten-Missbrauch und -Ab-h�ngigkeit bei psychiatrischen Patienten. Ergebnisse der AM�P-Studie. In: Hippius H,Ortner M, R�ther E (Hrsg.): Psychiatrische Erkrankungen in der �rztlichen Praxis. Ber-lin: Springer. S. 21–25.

Gruber SA, Silveri MM, Yurgelun-Todd DA (2007): Neuropsychological consequences ofopiate use. Neuropsychol Rev 17(3): 299–315.

Gr�ndel L (1999): Therapie von Schlafstçrungen. In: Platt D, Mutschler E (Hrsg.): Phar-makotherapie im Alter. Stuttgart: Wissenschaftliche Verlagsgesellschaft. S. 332–355.

Gupta S, Warner J (2008): Alcohol-related dementia: a 21st-century silent epidemic? Br JPsychiatry 193: 351–353.

Gutzmann H, Zank S (2005): Demenzielle Erkrankungen. Medizinische und psychosozialeInterventionen. Stuttgart: Kohlhammer.

14

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Haasen C, Prinzleve M, Gossop M, Fischer G, Casas M (2005): Relationship betweencocaine use and mental health problems in a sample of European cocaine powder orcrack users. World Psychiatry 4(3): 173–176.

Hach I, Rentsch A, Krappweis J, Kirch W (2004): Psychopharmakaverordnungen an �lte-ren Menschen. Z Gerontol Geriat 37: 214–220.

H�hnchen A, Gastpar M (1999): Kokain. In: Gastpar M, Mann K, Rommelspacher H(Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 263–275.

Hajak G, M�ller WE, Wittchen HU, Pittrow D, Kirch W (2003): Abuse and dependencepotential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of casereports and epidemiological data. Addiction 98: 1371–1378.

Hajek P, Stead LF, West R, Jarvis M, Lancaster T (2009): Relapse prevention interventionsfor smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No.: CD003999. DOI:101002/14651858.CD003999.pub3.

Hall RC, Zisook S (1981): Paradoxical reactions to benzodiazepines. Br J Clin Pharmacol11 (Suppl 1): S99–S104.

Hall SM (2007): Nicotine interventions with comorbid populations. Am J Prev Med33(6 Suppl): S406–S413.

Hall SM, Tunstall CD, Vila KL, Duffy J (1992): Weight gain prevention and smokingcessation: cautionary findings. Am J Public Health 82(6): 799–803.

Hall SM, Humfleet GL, Gorecki JA, MuÇoz RF, Reus VI, Prochaska JJ (2008): Older versusyounger treatment-seeking smokers: differences in smoking behavior, drug and alcoholuse, and psychosocial and physical functioning. Nicotine Tob Res 10(3): 463–470.

Hallhauer J, Bienstein C, Lehr U, Rçnsch H (2005): S�VIP – Studie zur �rztlichen Ver-sorgung in Pflegeheimen. Hannover: Vincentz.

Hamburgische Landesstelle gegen die Suchtgefahren (Hrsg.) (1989): Abh�ngigkeit im Alter.Mçglichkeiten und Grenzen der Hilfe. Hamburg: Eigenverlag.

Hamburgische Landesstelle gegen die Suchtgefahren (Hrsg.) (1990): Alter und Sucht. Ham-burg: Eigenverlag.

Hamilton AB, Grella CE (2009): Gender differences among older heroin users. J WomenAging 21(2): 111–124.

Hanlon CA, Wesley MJ, Roth AJ, Miller MD, Porrino LJ (2010): Loss of laterality inchronic cocaine users: an fMRI investigation of sensorimotor control. Psychiatry Res181(1): 15–23.

Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE Jr, LandermanLR, Pieper CF, Blazer DG, Cohen HJ (1998): Benzodiazepine use and cognitive functionamong community-dwelling elderly. Clin Pharmacol Ther 64(6): 684–692.

Harper C (2006): Thiamine (vitain B 1) deficiency and associated brain damage is stillcommon throughout the world and prevention is simple and safe! European Journal ofNeurology 13: 1078–1082.

Harper CG, Sheedy DL, Lara AI, Garrick TM, Hilton JM, Raisanen J (1998): Prevalence ofWernicke-Korsakoff syndrome in Australia: has thiamine fortification made a difference?Med J Aust 168(11): 542–545.

Harris CR, Albaugh B, Goldman D, Enoch MA (2003): Neurocognitive impairment due toalcohol consumption in an American Indian community. J Stud Alcohol 64: 458–466.

Harrison M, Busto U, Naranjo CA, Kaplan HL, Sellers EM (1984): Diazepam tapering indetoxification for high-dose benzodiazepine abuse. Clin Pharmacol Ther 36(4):527–533.

Hart CL, Morrison DS, Batty GD, Mitchell RJ, Smith GD (2010): Effect of body massindex and alcohol consumption on liver disease: analysis of data from two prospectivecohort studies. BMJ 2010;340:c1240. DOI: 101136/bmj.c1240.

15

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Harvey JA (2004): Cocaine effects on the developing brain: current status. Neurosci Bio-behav Rev 27(8): 751–764.

Haug H (1994): Morphologische Ver�nderungen des Zentralnervensystems. In: Olbrich E,Sames K, Schramm A (Hrsg.): Kompendium der Gerontologie. Landsberg: Ecomed.IV-5.9.1.1.

Haustein KO, Groneberg D (2008): Tabakabh�ngigkeit. Berlin: Springer.Hautzinger M (2000): Depression im Alter. Ein Therapieprogramm f�r �ltere depressive

Menschen. Weinheim: Psychologie Verlags Union.Havemann-Reinecke U, v Raison F (1998): Kçnnen Alterungsprozesse bzw. degenerative

Prozesse Sucht beeinflussen? In: Havemann-Reinecke U, Weyerer S, Fleischmann H(Hrsg.): Alkohol und Medikamente, Missbrauch und Abh�ngigkeit im Alter. Freiburg:Lambertus. S. 106–116.

Haw C, Stubbs J, Yorston G (2008): Antipsychotics for BPSD: an audit of prescribingpractice in a specialist psychiatric inpatient unit. Int Psychogeriatr 20(4): 790–799.

Haycock JW, Becker L, Ang L, Furukawa Y, Hornykiewicz O, Kish SJ (2003): Markeddisparity between age-related changes in dopamine and other presynaptic dopaminergicmarkers in human striatum. J Neurochem 87(3): 574–585.

He X, Sullivan EV, Stankovic RK, Harper CG, Pfefferbaum A (2007): Interaction of thia-mine deficiency and voluntary alcohol consumption disrupts rat corpus callosum ultra-structure. Neuropsychopharmacology 32(10): 2207–2216.

Heap LC, Pratt OE, Ward RJ, Waller S, Thomson AD, Shaw GK, Peters TJ (2002): Indivi-dual susceptibility to Wernicke-Korsakoff syndrome and alcoholism-induced cognitivedeficit: impaired thiamine utilization found in alcoholics and alcohol abusers. PsychiatrGenet 12(4): 217–224.

Heather N, Bowie A, Ashton H, McAvoy B, Spencer I, Brodie J, Giddings D (2004):Randomised controlled trial of two brief interventions against long-term benzodiazepineuse: outcome of intervention. Addict Res Theory 12: 141–154.

Heigl-Evers A, Helas I, Vollmer HC (1995): Suchtkranke in ihrer inneren und �ußerenRealit�t. Praxis der Suchttherapie im Methodenvergleich. Gçttingen: Vandenhoeck &Ruprecht.

Heigl-Evers A, Helas I, Vollmer HC (1997): Die Person des Therapeuten in der BehandlungSuchtkranker. Gçttingen: Vandenhoeck & Ruprecht.

Helmchen H, Baltes MM, Geiselmann B, Kanowski S, Linden M, Reischies FM, WagnerM, Wilms HU (1996): Psychische Erkrankungen im Alter. In: Mayer KU, Baltes PB(Hrsg.): Die Berliner Altersstudie. Berlin. Akademie Verlag. S. 185–220.

Helmchen H, Kanowski S (2001): Gerontopsychiatrie in Deutschland. Gegenw�rtige Ent-wicklung und zuk�nftige Anforderungen. In: Deutsches Zentrum f�r Altersfragen(Hrsg.): Gerontopsychiatrie und Alterspsychotherapie in Deutschland. Expertisen zumDritten Altenbericht der Bundesregierung, Bd. 4. Opladen: Leske + Buderich. S. 11–111.

Helmchen H, Kanowski S, Lauter H (2006): Ethik in der Altersmedizin. Stuttgart: Kohl-hammer.

Helzer JE, Burnam A, McEvoy LT (1991): Alcohol Abuse and Dependence. In: Robins LN,Regier DA (Eds.): Psychiatric Disorders in America: The Epidemiological CatchmentArea Study. New York: the Free Press. S. 81–115.

Hendricks PS, Prochaska JJ, Humfleet GL, Hall SM (2008): Evaluating the validities ofdifferent DSM-IV-based conceptual constructs of tobacco dependence. Addiction 103(7):1215–1223.

Herbeck DM, Hser YI, Lu AT, Stark ME, Paredes A (2006): A 12-year follow-up study ofpsychiatric symptomatology among cocaine-dependent men. Addict Behav 31(11):1974–1987.

16

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Herbert LE, Scherr PA, Beckett LA, Albert MS, Rosner B, Taylor JO, Evans DA (1993):Relation of smoking and low-to-moderate alcohol consumption to change in cognitivefunction: a longitudinal study in a defined community of older persons. Am J Epidemiol137(8): 881–891.

Herrero MJ, Domingo-Salvany A, Torrens M, Brugal MT; ITINERE Investigators (2008):Psychiatric comorbidity in young cocaine users: induced versus independent disorders.Addiction 103(2): 284–293.

Heuft G (2009): Der kçrperliche Alternsprozess als Organisator der Entwicklung in derzweiten H�lfte des Erwachsenenalters. �rztliche Psychotherapie 4(1): 5–9.

Higgins ST, Budney AJ, Bickel WK, Badger GJ (1994): Participation of significant others inoutpatient behavioral treatment predicts greater cocaine abstinence. Am J Drug AlcoholAbuse 20(1): 47–56.

Higgins ST, Wong CJ, Badger GJ, Ogden DE, Dantona RL (2000): Contingent reinforce-ment increases cocaine abstinence during outpatient treatment and 1 year of follow-up.J Consult Clin Psychol 68(1): 64–72.

Higgitt A, Lader HM, Fonagy P (1985): Clinical Management of Benzodiazepine Depen-dence. Br Med J 291: 688–690.

Hirshman E, Fisher J, Henthorn T, Arndt J, Passannante A (2003): Midazolam amnesia andretrieval from semantic memory: Developing methods to test theories of implicit memo-ry. Brain Cogn 53(3): 427–432.

Ho SC, Chan A, Woo J, Chong P, Sham A (2009): Impact of caregiving on health andquality of life: a comparative population-based study of caregivers for elderly personsand noncaregivers. J Gerontol A Biol Sci Med Sci 64(8): 873–879.

Hoffmann E, Schelhase T, Menning S (2009): Lebenserwartung und Sterbegeschehen. In:Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitr�gezur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung desStatistischen Bundesamtes, des Deutschen Zentrums f�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 92–104.

Hoffmann F, Glaeske G, Scharffetter W (2006): Zunehmender Hypnotikaverbrauch aufPrivatrezepten in Deutschland. Sucht 52: 360–366.

Hoffmann F, Scharffetter W, Glaeske G (2009): Verbrauch von Zolpidem und Zopiclon aufPrivatrezepten zwischen 1993 und 2007. Nervenarzt 52: 578–583.

Hoffmann NG, Olofsson O, Salen B, Wickstrom L (1995): Prevalence of abuse and depen-dency in chronic pain patients. Int J Addict 30: 919–927.

Hogan DB, Maxwell CJ, Fung TS, Ebly EM; Canadian Study of Health and Aging (2003):Prevalence and potential consequences of benzodiazepine use in senior citizens: resultsfrom the Canadian Study of Health and Aging. Can J Clin Pharmacol 10(2): 72–77.

Homewood J, Bond NW (1999): Thiamin deficiency and Korsakoff’s syndrome: failure tofind memory impairments following nonalcoholic Wernicke’s encephalopathy. Alcohol19: 75–84.

Howard AA, Klein RS, Schoenbaum EE (2003): Association of hepatitis C infection andantiretroviral use with diabetes mellitus in drug users. Clin Infect Dis 36(10):1318–1323.

Howes JB, Ryan J, Fairbrother G, O’Neill K, Howes LG (1996): Benzodiazepine prescri-bing in a Sydney teaching hospital. Med J Aust 165: 305–308.

Hser YI, Stark ME, Paredes A, Huang D, Anglin MD, Rawson R (2006): A 12-yearfollow-up of a treated cocaine-dependent sample. J Subst Abuse Treat 30(3): 219–226.

Hser YI, Huang D, Brecht ML, Li L, Evans E (2008): Contrasting trajectories of heroin,cocaine, and methamphetamine use. J Addict Dis 27(3): 13–21.

17

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Hudmon KS, Kilfoy BA, Prokhorov AV (2006): The epidemiology of tobacco use anddependence. Crit Care Nurs Clin North Am 18(1): 1–11.

Hughes JR, Keely J, Naud S (2004): Shape of the relapse curve and long-term abstinenceamong untreated smokers. Addiction 99(1): 29–38.

Hughes JR, Adams EH, Franzon MA, Maguire MK, Guary J (2005): A prospective study ofoff-label use of, abuse of, and dependence on nicotine inhaler. Tob Control 14: 49–54.

Hughes JR, Kalman D (2006): Do smokers with alcohol problems have more difficultyquitting? Drug Alcohol Depend 82(2): 91–102.

Hughes JR, Stead LF, Lancaster T (2007): Antidepressants for smoking cessation. CochraneDatabase Syst Rev Issue 1. Art. No.: CD000031. DOI: 101002/14651858.CD000-031.pub3.

Huntgeburth E (2010): persçnl. Mitteilung.Husemoen LL, Osler M, Godtfredsen NS, Prescott E (2004): Smoking and subsequent risk

of early retirement due to permanent disability. Eur J Public Health 14(1): 86–92.Husten CG, Shelton DM, Chrismon JH, Lin YC, Mowery P, Powell FA (1997): Cigarette

smoking and smoking cessation among older adults: United States, 1965–1994. TobControl 6(3): 175–180.

Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD (1997):Predictors of smoking cessation in a cohort of adult smokers followed for five years. TobControl 6 (Suppl 2): S57–S62.

Ibach B (2009): Polypharmazie in der Gerontopsychiatrie. In: Messer T, Schmauss M(Hrsg.): Polypharmazie in der Behandlung psychischer Erkrankungen. Heidelberg: Sprin-ger. S. 144–177.

Iga JI, Araki M, Ishimoto Y, Ohmori T (2001): A case of Korsakoff’s syndrome improvedby high doses of donepezil. Alcohol Alcohol 36: 553–555.

Iliffe S, Curran HV, Collins R, Yuen Kee SC, Fletcher S, Woods B (2004): Attitudes tolong-term use of benzodiazepine hypnotics by older people in general practice: findingsfrom interviews with service users and providers. Aging & Mental Health 8: 242–248.

Iuvone T, Esposito G, De Filippis D, Scuderi C, Steardo L (2009): Cannabidiol: a promisingdrug for neurodegenerative disorders? CNS Neurosci Ther 15(1): 65–75.

Izaute M, Paire-Ficout L, Bacon E (2004): Benzodiazepines and semantic memory: effectsof lorazepam on the Moses illusion. Psychopharmacology 172(3): 309–315.

Izaute M, Bacon E (2005): Effects of the amnesic drug lorazepam on complete and partialinformation retrieval and monitoring accuracy. Psychopharmacology 188(4): 472–481.

Jacobi J (2005): Anti-Aging: Sinnbild, Sehnsucht, Wirklichkeit. In: Jacobi et al. (Hrsg.):Kursbuch Anti-Aging. Stuttgart: Thieme. S. 2–13.

Jacobsen LK, Picciotto MR, Heath CJ, Frost SJ, Tsou KA, Dwan RA, Jackowski MP,Constable RT, Mencl WE (2007): Prenatal and adolescent exposure to tobacco smokemodulates the development of white matter microstructure. J Neurosci 27(49):13491–13498.

Jager G, Kahn RS, Van Den Brink W, Van Ree JM, Ramsey NF (2006): Long-term effects offrequent cannabis use on working memory and attention: an fMRI study. Psychophar-macology 185(3): 358–368.

Jamison RN, Schein JR, Vallow S, Ascher S, Vorsanger GJ, Katz NP (2003): Neuropsycho-logical effects of long-term opioid use in chronic pain patients. J Pain Symptom Manage26(4): 913–921.

J�ncke L (2004): Neuropsychologie des Alterns. In: Kruse A, Martin M (Hrsg.): Enzyklo-p�die der Gerontologie. Bern: Huber. S. 207–223.

Jarvenpaa T, Rinne JO, Koskenvuo M, Raiha I, Kaprio J (2005): Binge drinking in midlifeand dementia risk. Epidemiology 16: 766–771.

18

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Jeste DV, Alexopoulos GS, Bartels SJ, Cummings JL, Gallo JJ, Gottlieb GL, Halpain MC,Palmer BW, Patterson TL, Reynolds CF 3rd, Lebowitz BD (1999): Consensus statementon the upcoming crisis in geriatric mental health: research agenda for the next 2 decades.Arch Gen Psychiatry 56(9): 848–853.

Jha SH, Knapp CM, Kornetsky C (2004): Effects of morphine on brain-stimulation rewardthresholds in young and aged rats. Pharmacol Biochem Behav 79(3): 483–490.

Johansson BA, Berglund M, Lindgren A (2006): Efficacy of maintenance treatment withnaltrexone for opioid dependence: a meta-analytical review. Addiction 101(4): 491–503.

Johansson BA, Berglund M, Lindgren A (2007): Efficacy of maintenance treatment withmethadone for opioid dependence: a meta-analytical study. Nord J Psychiatry 61(4):288–295.

John U, Meyer C, Rumpf HJ, Hapke U (2004a): Depressive disorders are related to nico-tine dependence in the population but do not necessarily hamper smoking cessation.J Clin Psychiatry 65(2): 169–176.

John U, Meyer C, Rumpf HJ, Hapke U (2004b): Smoking, nicotine dependence and psy-chiatric comorbidity – a population-based study including smoking cessation after threeyears. Drug Alcohol Depend 76(3): 287–295.

John U, Hanke M, Rumpf HJ, Thyrian JR (2005): Smoking status, cigarettes per day, andtheir relationship to overweight and obesity among former and current smokers in anational adult general population sample. Int J Obes 29(10): 1289–1294.

John U, Meyer C, Rumpf HJ, Hapke U, Schumann A (2006): Predictors of increased bodymass index following cessation of smoking. Am J Addict 15(2): 192–197.

Johnell K, Fastbom J (2009): The use of benzodiazepines and related drugs amongst olderpeople in Sweden: associated factors and concomitant use of other psychotropics. Int JGeriatr Psychiatry 24(7): 731–738.

Johnson KH, Bazargan M, Cherpitel CJ (2001): Alcohol, tobacco, and drug use and theonset of type 2 diabetes among inner-city minority patients. J Am Board Fam Pract 14(6):430–436.

Joseph H, Stancliff S, Langrod J (2000): Methadone maintenance treatment (MMT): areview of historical and clinical issues. Mt Sinai J Med 67(5–6): 347–364.

Joyce EM (1994): Aetiology of alcoholic brain damage: alcoholic neurotoxicity or thiaminemalnutrition? Br Med Bull 50: 99–114.

Kamboj SK, Curran HV (2006): Neutral and emotional episodic memory: global impair-ment after lorazepam or scopolamine. Psychopharmacology 188(4): 482–488.

Kan CC, Breteler MHM, Timmermans EAY, van der Ven AHGS, Zitman FG (1999):Scalability, Reliability, and Validity of the Benzodiazepine Dependence Self-Report Ques-tionnaire in Outpatient Benzodiazepine Users. Compr Psychiatry 40(4): 283–291.

Kan CC, Breteler MH, van der Ven AH, Zitman FG (2001a): Cross-validation of thebenzodiazepine dependence self-report questionnaire in outpatient benzodiazepine users.Compr Psychiatry 42(5): 433–439.

Kan CC, an der Ven AH, Breteler MH, Zitman FG (2001b): Latent Trait Standardizationof the Benzodiazepine Dependence Self-Report Questionnaire Using the Rasch ScalingModel. Compr Psychiatry 42(5): 424–432.

Kan CC, Zitman FG, Breteler MHM (2001c): Multidimension Assessment of Benzodiaze-pine Dependence. Vortrag APA Conference New Orleans 8–5-2001. http://cckan.ruhos-ting.nl/KanBdepAPA.pdf Zugriff 08. 01. 2010

Karkos J (1991): Neurotoxizit�t von Benzodiazepinen. Fortschr Neurol Psychiat 59:498–520.

19

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Kasahara H, Krasawa A, Ariyasu T, Thukahara T, Satou J, Ushijima S (1996): AlcoholDementia and Alcohol Delirium in Aged Alcoholics. Psychiatr Clin Neurosci 50:115–123.

Kato N (1991): Clinical concept of alcoholic dementia. Arukoru Kenkyuto Yakubutsu Ison26: 119–133.

Kato N (1996): A case with primary alcoholic dementia – an investigation of dementiaassociated with alcoholism. Jpn J Psychiatry Res Alcohol 5: 15–24.

Katz NP, Adams EH, Chilcoat H, Colucci RD, Comer SD, Goliber P, Grudzinskas C,Jasinski D, Lande SD, Passik SD, Schnoll SH, Sellers E, Travers D, Weiss R (2007):Challenges in the development of prescription opioid abuse-deterrent formulations.Clin J Pain 23(8): 648–660.

Kaul M (2009): HIV-1 associated dementia: update on pathological mechanisms and the-rapeutic approaches. Curr Opin Neurol 22(3): 315–320.

Kawachi I, Colditz GA, Stampfer MJ, Willett WC, Manson JE, Rosner B, Hunter DJ,Hennekens CH, Speizer FE (1993): Smoking cessation in relation to total mortality ratesin women. A prospective cohort study. Ann Intern Med 119(10): 992–1000.

Kempermann G (2007): Nicht ausgeliefert an Zeit und Welt. Die Plastizit�t des alterndenGehirns. In: Gruss P (Hrsg.): Die Zukunft des Alterns. M�nchen: Beck. S. 35–50.

Kenfield SA, Stampfer MJ, Rosner BA, Colditz GA. (2008): Smoking and smoking cessa-tion in relation to mortality in women. JAMA 299(17): 2037–2047.

Kenna GA, Nielsen DM, Mello P, Schiesl A, Swift RM (2007): Pharmacotherapy of dualsubstance abuse and dependence. CNS Drugs 21(3): 213–237.

Kenney BA, Holahan CJ, Holahan CK, Brennan PL, Schutte KK, Moos RH (2009): Depres-sive symptoms, drinking problems, and smoking cessation in older smokers. AddictBehav 34(6–7): 548–553.

Kiefer F, Grosshans M (2009): Beitrag der Suchtforschung zum Verst�ndnis der Adipositas.Nervenarzt 80(9): 1040–1049.

Kim KY, Ke V, Adkins LM (2004): Donepezil for alcohol-related dementia: a case report.Pharmacotherapy 24: 419–412.

Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA (1999a): Benzodiazepineuse among the elderly in the community. Int J Geriatr Psychiatry 14: 280–284.

Kirby M, Denihan A, Bruce I, Radic A, Coakley D, Lawlor BA (1999b): Influence ofsymptoms of anxiety on treatment of depression in later life in primary care: question-naire survey. BMJ 318: 379–380.

Kirchen-Peters S (2008): Gerontopsychiatrischer Konsiliar- und Liaisondienst – Pionierewarten auf Nachahmer. Zeitschrift f�r Gerontologie und Geriatrie 41: 467–474.

Kirchner JE, Zubritsky C, Cody M, Coakley E, Chen H, Ware JH, Oslin DW, Sanchez HA,Durai UN, Miles KM, Llorente MD, Costantino G, Levkoff S (2007): Alcohol consump-tion among older adults in primary care. J Gen Intern Med 22(1): 92–97.

Kissel EC, Pukay-Martin ND, Bornstein RA (2005): The relationship between age andcognitive function in HIV-infected men. J Neuropsychiatry Clin Neurosci 17(2):180–184.

Klotz U (1986): Klinische Pharmakologie der Benzodiazepine. In: Hippius H, Engel RR,Laakmann G (Hrsg.): Benzodiazepine. R�ckblick und Ausblick. Berlin: Springer.S. 32–39.

Klotz U (1995): Benzodiazepin-Tranquilizer – Pharmakokinetik. In: Riederer P, Laux G,Pçldinger W (Hrsg.): Neuro-Psycho-Pharmaka. Bd. 2: Tranquilizer und Hypnotika.Wien: Springer. S. 13–23.

20

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Knopman DS, Petersen RC, Cha RH, Edland SD, Rocca WA (2006): Incidence and causesof nondegenerative nonvascular dementia: a population-based study. Arch Neurol 63:218–221.

Kochsiek K (2009): Eckpunkte f�r Empfehlungen der gemeinsamen Arbeitsgruppe „Chan-cen und Probleme einer alternden Gesellschaft“ der Deutschen Akademie der Natur-forscher Leopoldina und der Deutschen Akademie f�r Technikwissenschaften acatech.In: Kochsiek K (Hrsg.): Altern und Gesundheit. (Altern in Deutschland Band 7). NovaActa Leopoldina NF 105, Nr. 369: 53–58. Halle (Saale): Deutsche Akademie der Natur-forscher Leopoldina/Stuttgart: Wissenschaftliche Verlagsgesellschaft.

Kolitzus H (1997): Die Liebe und der Suff . . . Schicksalsgemeinschaft Suchtfamilie. M�n-chen: Kçsel.

Kçrkel J, Kruse G (1997): Mit dem R�ckfall leben. Bonn: Psychiatrie-Verlag, 3. Aufl.Kçrkel J, Veltrup C (2003): Motivational Interviewing. Eine �bersicht. Suchttherapie 4:

115–124.Kouimtsidis C, Padhi A (2007): A case of late-onset dependence on cocaine and crack.

Addiction 102(4): 666–667.Kouyanou K, Pither CE, Wessely S (1997): Medication misuse, abuse and dependence in

chronic pain patients. J Psychosom Res 43: 497–504.Kraemer KL, Mayo-Smith MF, Calkins DR (1997): Impact of age on the severity, course,

and complications of alcohol withdrawal. Arch Intern Med 157(19): 2234–2241.Kraus L, Semmler C, Hose A, Kunz-Ebrecht S, H�ffer I, Orth B (2004): Epidemiologie,

Pr�vention und Therapie von Kokainkonsum und kokainbezogenen Stçrungen – eineLiteratur�bersicht. IFT-Berichte Bd. 144. M�nchen: Institut f�r Therapieforschung (IFT).

Kraus L, Augustin R, Kunz-Ebrecht S, Orth B (2007): Drug use patterns and drug-relateddisorders of cocaine users in a sample of the general population in Germany. Eur AddictRes 13(2): 116–125.

Kraus L, Pfeiffer-Gerschel T, Pabst A (2008): Cannabis und andere illegale Drogen –Pr�valenz, Konsummuster und Trends. Ergebnisse des epidemiologischen Suchtsurveys2006. Sucht 54 (Sonderheft 1): S16–S25.

Krausz M, Lambert M (2000): Cannabis. In: Uchtenhagen A, Zieglg�nsberger W (Hrsg.):Suchtmedizin. M�nchen: Urban & Fischer. S. 77–82.

Krishnan S, Cairns R, Howard R (2009): Cannabinoids for the treatment of dementia.Cochrane Database Syst Rev 15(2): CD007204.

Kriston L, Hçlzel L, Weiser AK, Berner MM, H�rter M (2008): Meta-analysis: Are 3 Ques-tions Enough to Detect Unhealthy Alcohol Use? Ann Intern Med 149(12): 879–888.

Krçger C (2005): Die Psychologie des Rauchens – Grundlage f�r eine psychologischeBehandlung. In: Batra A (Hrsg.): Tabakabh�ngigkeit. Wissenschaftliche Grundlagenund Behandlung. Stuttgart: Kohlhammer. S. 83–92.

Kroll LE, Ziese T (2009): Kompression oder Expansion der Morbidit�t? In: Bçhm K,Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitr�ge zurGesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statis-tischen Bundesamtes, des Deutschen Zentrums f�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 105–112.

Kruse A (2002): Gesund altern. Stand der Pr�vention und Entwicklung erg�nzender Pr�-ventionsstrategien. Schriftenreihe des Bundesministeriums f�r Gesundheit, Bd. 146.Baden-Baden: Nomos.

Kudoh A, Takase H, Takahira Y, Takazawa T (2004): Postoperative confusion increases inelderly long-term benzodiazepine users. Anesth Analg 99(6): 1674–1678.

K�lpmann WR (2008): Vergiftungen und Drogenabusus. In: Thomas L (Hrsg.): Labor undDiagnose. Frankfurt/M.: TH-Books Verlagsgesellschaft. S. 1569–1584.

21

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

K�nig G, D�twyler S, Eschen A, Schreiter-Gasser U (2006): Unrecognised long-lastingtramadol-induced delirium in two elderly patients. A case report. Pharmacopsychiatry39(5): 194–199.

Kunze C (2009): Das Elend des Alters. Hellenistische Genreskulpturen von Fischern, Land-leuten und alten Frauen. In: Landschaftsverband Rheinland, LVR LandesMuseum Bonn(Hrsg.): Alter in der Antike. Die Bl�te des Alters aber ist die Weisheit. Mainz: vonZabern. S. 107–123.

Ladewig D (1990): Tranquilizer: Problematik von Mißbrauch und Abh�ngigkeit. In: HerzA, Hippius H, Spann W (Hrsg.): Psychopharmaka heute. Berlin: Springer. S. 140–149.

Ladewig D (1992): Abusus und Abh�ngigkeit. In: Riederer P, Laux G, Pçldinger W (Hrsg.):Neuro-Psycho-Pharmaka. Bd. 1: Allgemeine Grundlagen der Pharmakopsychiatrie.Wien: Springer. S. 411–423.

Lampert T (2009): Soziale Ungleichheit und Gesundheit im hçheren Lebensalter. In: BçhmK, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitr�ge zurGesundheitsberichterstattung des Bundes. Eine gemeinsame Verçffentlichung des Statis-tischen Bundesamtes, des Deutschen Zentrums f�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. 212–133.

Lampert T, List SM (2009): Tabak – Zahlen und Fakten zum Konsum. In: Deutsche Haupt-stelle f�r Suchtgefahren (DHS) (Hrsg.): Jahrbuch Sucht 2009. Geesthacht: Neuland.S. 51–71.

Lancaster T, Hajek P, Stead LF, West R, Jarvis MJ (2006): Prevention of relapse afterquitting smoking: a systematic review of trials. Arch Intern Med 166(8): 828–835.

Landkreis Esslingen (Hrsg.) (1992): Sucht im Alter. Verleugnet – geduldet – verordnet.3. Fachtagung Gerontopsychiatrie 01.–02. 04. 1992. Esslingen: Eigenverlag.

Lang I, Wallace RB, Huppert FA, Melzer D (2007): Moderate alcohol consumption in olderadults is associated with better cognition and well-being than abstinence. Age Ageing36(3): 2562–2561.

Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ (2001): The impact ofharm-reduction-based methadone treatment on mortality among heroin users. Am J Pub-lic Health 91(5): 774–780.

Launer LJ, Feskens EJ, Kalmijn S, Kromhout D (1996): Smoking, drinking, and thinking.The Zutphen Elderly Study. Am J Epidemiol 143(3): 219–227.

Laurijssens BE, Greenblatt DJ (1996): Pharmacokinetic-Pharmacodynamic Relationshipsfor Benzodiazepines. Clin Pharmacokinet 30: 52–76.

Lauterbach W (2002): Großelternschaft und Mehrgenerationenfamilien – soziale Realit�toder demographischer Mythos? Z Gerontol Geriat 35: 540–555.

Laux G (1995a): Aktueller Stand der Behandlung mit Benzodiazepinen. Nervenarzt 66:311–322.

Laux G, Kçnig W (1986): Benzodiazepin-Abusus. Epidemiologische und klinisch-klassifi-katorische Aspekte. In: Heimann H, Gaertner HJ (Hrsg.): Das Verh�ltnis der Psychiatriezu ihren Nachbardisziplinen. Berlin: Springer. S. 262–272.

Lee HS, Mericle AA, Ayalon L, Are�n PA (2009): Harm reduction among at-risk elderlydrinkers: a site-specific analysis from the multi-site Primary Care Research in SubstanceAbuse and Mental Health for Elderly (PRISM-E) study. Int J Geriatr Psychiatry 24(1):54–60.

Leesemann S (1995): Suchtkrankheiten bei �rztinnen und �rzten. Berufsstress und hoheDrogenakzeptanz. Dt �rztebl 92(47): A-3300–A-3305.

Legnaro A (2000): Rausch und Sucht in der Sozial- und Kulturgeschichte Europas. In:Uchtenhagen A, Zieglg�nsberger W (Hrsg.): Suchtmedizin. M�nchen: Urban & Fischer.S. 8–21.

22

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL,Leonard DGB, Shields PG, Epstein LH (2004): Changes in food reward following smo-king cessation: a pharmacogenetic investigation. Psychopharmacology 174: 571–577.

Letenneur L (2004): Risk of dementia and alcohol and wine consumption: a review ofrecent results. Biol Res 37: 189–193.

Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994):Psychoactive Medications and Injurious Vehicle Collisions Involving Older Drivers. Epi-demiology 5: 591–598.

Levens S, Dyer AM, Zubritsky C, Knott K, Oslin DW (2005): Gambling among older,primary-care patients: an important public health concern. Am J Geriatr Psychiatry13(1): 69–76.

Lexikon der Neurowissenschaften. (2000) Stichwort „Altern“. Bd. 1. Heidelberg: Spek-trum Akademischer Verlag.

Liberto JG, Oslin DW (1995): Early Versus Late Onset of Alcoholism in the Elderly. IntJ Addict 30: 1799–1818.

Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP (2002): Reduced frontal white matterintegrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psy-chiatry 51(11): 890–895.

Lim KO, Wozniak JR, Mueller BA, Franc DT, Specker SM, Rodriguez CP, Silverman AB,Rotrosen JP (2008): Brain macrostructural and microstructural abnormalities in cocainedependence. Drug Alcohol Depend 92(1–3): 164–172.

Lindemann RD, Wayne SJ, Baumgartner RN, Garry PJ (2005): Cognitive function indrinkers compared to abstainers in the New Mexico elder health survey. J Gerontol ABiol Sci Med Sci 60: 1065–1070.

Linden M, Bohlken J (1992): Compliance und Psychopharmakotherapie. In: Riederer P,Laux G, Pçldinger W (Hrsg.): Neuro-Psycho-Pharmaka. Bd. 1: Allgemeine Grundlagender Pharmakopsychiatrie. Wien, New York: Springer. S. 201–209.

Linden M, B�r T, Geiselmann B (1998): Patient treatment insistence and medication cra-ving in long-term low-dosage benzodiazepine prescriptions. Psychol Med 28: 721–729.

Lindinger P (2005): Die Motivation des Rauchers zur Abstinenz. In: Batra A (Hrsg.):Tabakabh�ngigkeit. Wissenschaftliche Grundlagen und Behandlung. Stuttgart: Kohl-hammer. S. 115–131.

Ling PM, Glantz SA (2004): Tobacco industry research on smoking cessation. Recapturingyoung adults and other recent quitters. J Gen Intern Med 19(5 Pt 1): 419–426.

Lissner L, Bengtsson C, Lapidus L, Bjçrkelund C (1992): Smoking initiation and cessationin relation to body fat distribution based on data from a study of Swedish women. AmJ Public Health 82(2): 273–275.

Liu B, Reeves G, Beral V, on behalf of the Million Women Study Collaborators (2010):Body mass index and risk of liver cirrhosis in middle aged UK women: prospective study.BMJ 2010;340:c912. DOI: 101136/bmj.c912.

Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE (1995): Falls Among Older People:Relationship to Medication Use and Orthostatic Hypotension. J Am Geriatr Soc 43:1141–1145.

Liu H, Li L, Hao Y, Cao D, Xu L, Rohrbaugh R, Xue Z, Hao W, Shan B, Liu Z (2008):Disrupted white matter integrity in heroin dependence: a controlled study utilizing dif-fusion tensor imaging. Am J Drug Alcohol Abuse 34(5): 562–575.

Livingston G, Johnston K, Katona C, Paton J, Lyketsos CG, Old Age Task Force of theWorld Federation of Biological Psychiatry (2005): Systematic review of psychologicalapproaches to the management of neuropsychiatric symptoms of dementia. Am J Psy-chiatry 162: 1996–2021.

23

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Lçvheim H, Sandman PO, Kallin K, Karlsson S, Gustafson Y (2006): Relationship betweenantipsychotic drug use and behavioral and psychological symptoms of dementia in oldpeople with cognitive impairment living in geriatric care. Int Psychogeriatr 18(4):713–726.

Lçvheim H, Karlsson S, Gustafson Y (2008a): The use of central nervous system drugs andanalgesics among very old people with and without dementia. Pharmacoepidemiol DrugSaf 17(9): 912–918.

Lçvheim H, Sandman PO, Kallin K, Karlsson S, Gustafson Y (2008b): Symptoms of mentalhealth and psychotropic drug use among old people in geriatric care, changes between1982 and 2000. Int J Geriatr Psychiatry 23(3): 289–294.

Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R (2004): Alcohol intake and risk ofdementia. JAGS 52: 540–546.

L�ddens H, Wiedemann K (2008): Anxiolytika und Hypnotika. In Holsboer F, Gr�nder G,Benkert O (Hrsg.): Handbuch der Psychopharmakotherapie. Berlin: Springer.S. 591–626

Luderer HJ (1986): Suchtgefahren im Alter. Nervenheilkunde 5: 195–198.Luderer HJ, Schulz M, Mayer M (1995): Langzeiteinnahme von Benzodiazepinen – Krank-

heitsentwicklung, Folgeerscheinungen, Behandlung. Psychiat Prax 22: 231–234.Lundqvist T (2005): Cognitive consequences of cannabis use: comparison with abuse of

stimulants and heroin with regard to attention, memory and executive functions. Phar-macol Biochem Behav 81(2): 319–330.

L�tzelschwab J (2009): Haus Harmonie. Ein Pilotprojekt f�r �ltere Drogenabh�ngige inBasel Land. Vortrag bei der Fachtagung „�ltere Drogenabh�ngige – Versorgungskon-zepte an der Schnittstelle zwischen Sucht- und Altenhilfe“ am 22. 10. 2009 in M�nchen.http://www.paritaet-bayern.de/webcode/link.php?id=954 – Zugriff 30. 04. 2010.

Lyvers M, Yakimoff M (2003): Neuropsychological correlates of opioid dependence andwithdrawal. Addict Behav 28(3): 605–611.

Maercker A (Hrsg.) (2002): Alterspsychotherapie und klinische Gerontopsychologie. Ber-lin: Springer.

Mahoney R, Regan C, Katona C, Livingston G (2005): Anxiety and depression in familycaregivers of people with Alzheimer disease: the LASER-AD study. Am J Geriatr 13(9):795–801.

Maier W, Franke P, Linz M (1999): Mehrfachdiagnosen (Komorbidit�t). In: Gastpar M,Mann K, Rommelspacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme.S. 183–201.

Mancuso CE, Tanzi MG, Gabay M (2004): Paradoxical reactions to benzodiazepines:literature review and treatment options. Pharmacotherapy 24(9): 1177–1185.

Mann K, Rommelspacher H (1999): Alkohol. In: Gastpar M, Mann K, Rommelspacher H(Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 183–201.

Mann K, Diehl A, Hein J, Heinz A (2009a): Alkoholabh�ngigkeit. In: Vorderholzer U,Hohagen F (Hrsg.): Therapie psychischer Stçrungen. State of the Art 2008/2009. M�n-chen, Urban & Fischer. 4. Aufl. S. 23–38.

Manzardo AM, Penick EC (2006): A theoretical argument for inherited thiamine insensi-tivity as one possible biological cause of familial alcoholism. Alcohol Clin Exp Res 30(9):1545–1550.

Mardorf S, Bçhm K (2009): Bedeutung der demografischen Alterung f�r das Ausgaben-geschehen im Gesundheitswesen. In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesund-heit und Krankheit im Alter. Beitr�ge zur Gesundheitsberichterstattung des Bundes. Einegemeinsame Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrumsf�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 247–266.

24

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Marlow SP, Stoller JK (2003): Smoking cessation. Respir Care 48(12): 1238–1254.Marteau T, Ashcroft R, Oliver A (2009): Using financial incentives to achieve healthy

behaviour. BMJ 338: 983–985.Martell BA, Orson FM, Poling J, Mitchell E, Rossen RD, Gardner T, Kosten TR (2009):

Cocaine Vaccine for the Treatment of Cocaine Dependence in Methadone-MaintainedPatients. A Randomized, Double-blind, Placebo-Controlled Efficacy Trial. Arch GenPsychiatry 66(10): 1116–1123.

Martin J, Matthews A, Martin F, Kirkby KC, Alexander J, Daniels B (2002): Effects oflorazepam and oxazepam on perceptual and procedural memory functions. Psychophar-macology 164(3): 262–267.

Martin PR, Adinoff B, Eckardt MJ, Stapleton JM, Bone GA, Rubinow DR, Lane E, Lin-noila M (1989): Effective pharmacotherapy of alcoholic amnestic disorder with fluvox-amine. Preliminary findings. Arch Gen Psychiatry 46: 617–621.

Martin PR, Adinoff B, Lane E, Stapleton JM, Bone GA, Weingartner H, Linnoila M,Eckardt MJ (1995): Fluvoxamine treatment of alcoholic amnestic disorder. Eur Neuro-psychopharmacol 5: 27–33.

Martin PR, Singleton CK, Hiller-Sturmhofel S (2003): The role of thiamine deficiency inalcoholic brain disease. Alcohol Res Health 27: 134–142.

Mart�n-S�nchez E, Furukawa TA, Taylor J, Martin JL (2009): Systematic review and meta-analysis of cannabis treatment for chronic pain. Pain Med 10(8): 1353–1368.

Masica AL, Girard TD, Wilkinson GR, Thomason JW, Truman Pun B, Nair UB, Light RW,Canonico AE, Dunn J, Pandharipande P, Shintani AK, Ely EW (2007): Clinical sedationscores as indicators of sedative and analgesic drug exposure in intensive care unitpatients. Am J Geriatr Pharmacother 5(3): 218–213.

M�ulen B (1992): Abh�ngigkeit in Pflegeberufen. In: Deutsche Hauptstelle gegen die Sucht-gefahren (Hrsg.): Medikamentenabh�ngigkeit. Freiburg: Lambertus. S. 217–223.

M�ulen B (1993): Sucht in helfenden Berufen. Abh�ngigkeitserkrankungen bei Kranken-pflegekr�ften und �rzten. Psychiat Prax 20 (Sonderheft 1): 42–45.

Maurage P, Pesenti M, Philippot P, Joassin F, Campanella S (2009): Latent deleteriouseffects of binge drinking over a short period of time revealed only by electrophysiologicalmeasures. J Psychiatry Neurosci 34(2): 111–118.

McFall M, Saxon AJ, Thompson CE, Yoshimoto D, Malte C, Straits-Troster K, Kanter E,Zhou XH, Dougherty CM, Steele B. (2005): Improving the rates of quitting smoking forveterans with posttraumatic stress disorder. Am J Psychiatry 162(7): 1311–1319.

McGregor C, Machin A, White JM (2003): In-patient benzodiazepine withdrawal: com-parison of fixed and symptom-triggered taper methods. Drug Alcohol Rev 22(2):175–180.

McGuire LC, Ajani UA, Ford ES (2007): Cognitive functioning in late life: the impact ofmoderate alcohol consumption. Ann Epidemiol 17(2): 93–99.

McIntosh C, Kippen V, Hutcheson F, McIntosh A (2005): Parenteral thiamine use in theprevention and treatment of Wernicke-Korsakoff syndrome. Psychiatric Bulletin 29:94–97.

McKee SA, Harrison EL, O’Malley SS, Krishnan-Sarin S, Shi J, Tetrault JM, Picciotto MR,Petrakis IL, Estevez N, Balchunas E (2009): Varenicline reduces alcohol self-adminis-tration in heavy-drinking smokers. Biol Psychiatry 66(2): 185–190.

McKibbin CL, Ancoli-Israel S, Dimsdale J, Archuleta C, von Kanel R, Mills P, PattersonTL, Grant I (2005): Sleep in spousal caregivers of people with Alzheimer’s disease. Sleep28(10): 1245–1250.

25

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Melchinger H, Schnabel R, Wyns B (1992): Verordnungpraxis von Medikamenten mitAbh�ngigkeitspotential. Schriftenreihe des Bundesministeriums f�r Gesundheit, Bd. 13.Baden-Baden: Nomos.

Mendelson WB (1992): Clinical Distinctions between Long-Acting and Short-Acting Ben-zodiazepines. J Clin Psychiatry 53(Suppl): 4–7.

Mendelson WB (1996): The Use of Sedative/Hypnotic Medication and its Correlation WithFalling Down in Hospital. Sleep 19: 698–701.

Mendelson WB, Thompson C, Franko T (1996): Adverse Reactions to Sedative/Hypnotics:Three Years’ Experience. Sleep 19: 702–706.

Menefee LA, Frank ED, Crerand C, Jalali S, Park J, Sanschagrin K, Besser M (2004): Theeffects of transdermal fentanyl on driving, cognitive performance, and balance in patientswith chronic nonmalignant pain conditions. Pain Med 5(1): 42–49.

Menninger JA (2002): Assessment and treatment of alcoholism and substance-related dis-orders in the elderly. Bull Menninger Clin 66(2): 166–183.

Merfert-Diete C (2009): Daten, Zahlen und Fakten. In: Deutsche Hauptstelle f�r Sucht-gefahren (DHS) (Hrsg.): Jahrbuch Sucht 2009. Geesthacht: Neuland. S. 7–20.

Merritt P, Hirshman E, Hsu J, Berrigan M (2005): Metamemory without the memory: arepeople aware of midazolam-induced amnesia? Psychopharmacology 177(3): 336–343.

Merritt P, Hirshman E, Zamani S, Hsu J, Berrigan M (2006): Episodic representationssupport early semantic learning: evidence from midazolam induced amnesia. BrainCogn 61(2): 219–223.

Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP (2008): Smoking cessation rates in theUnited States: a comparison of young adult and older smokers. Am J Public Health98(2): 317–322.

Michna E, Ross EL, Hynes WL, Nedeljkovic SS, Soumekh S, Janfaza D, Palombi D, JamsonRN (2004): Predicting aberrant drug behavior in patients treatment for chronic pain:impoartance of abuse history. J Pain Symptom Manage 28: 250–258.

Mimura M, Komatsu S, Kato M, Yoshimasu H, Moriyama Y, Kashima H (2005): Furtherevidence for a comparable memory advantage of self-performed tasks in Korsakoff’ssyndrome and nonamnesic control subjects. J Int Neuropsychol Soc 11(5): 545–553.

Mineur YS, Picciotto MR (2008): Genetics of nicotinic acetylcholine receptors: Relevanceto nicotine addiction. Biochem Pharmacol 75(1): 323–333.

Mintzer MZ, Correia CJ, Strain EC (2004): A dose-effect study of repeated administrationof buprenorphine/naloxone on performance in opioid-dependent volunteers. Drug Alco-hol Depend 74(2): 20520–20529.

Mintzer MZ, Griffiths RR (2005): Drugs, memory, and metamemory: a dose-effect studywith lorazepam and scopolamine. Exp Clin Psychopharmacol 13(4): 336–347.

Mintzer MZ, Griffiths RR (2007): Differential effects of scopolamine and lorazepam onworking memory maintenance versus manipulation processes. Cogn Affect Behav Neu-rosci 7(2): 12012–12019.

Mizoue T, Ueda R, Tokui N, Hino Y, Yoshimura T (1998): Body mass decrease after initialgain following smoking cessation. Int J Epidemiol 27(6): 984–988.

Moffoot A, O’Carroll RE, Murray C, Dougall N, Ebmeier K, Goodwin GM (1994):Clondine infusion increases uptake of 99mTc-Exametazimein anterior cingulate cortexin Korsakoff’s psychosis. Psychol Med 24: 53–61.

Mol AJJ, Oude Voshaar RC, Gorgels WJMJ, Breteler MHM, van Balkom AJLM, van deLisdonk EH, van der Ven AHGS, Zitman FG (2003): Development and psychometricevaluation of the Benzodiazepine Craving Questionnaire. Addiction 98: 1143–1152.

Molter-Bock E, Hasford J, Pfundstein T (2006): Psychopharmakologische Behandlungs-praxis in M�nchener Altenpflegeheimen. Z Gerontol Geriat 39: 336–343.

26

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Molyneux GJ, McCarthy GM, McEniff S, Cryan M, Conroy RM (2008): Prevalence andpredictors of carer burden and depression in carers of patients referred to an old agepsychiatric service. Int Psychogeriatr 20(6): 1193–1202.

Mooney ME, Herin DV, Schmitz JM, Moukaddam N, Green CE, Grabowski J (2009):Effects of oral methamphetamine on cocaine use: a randomized, double-blind, placebo-controlled trial. Drug Alcohol Depend 101(1–2): 34–41.

Moore AA, Seeman T, Morgenstern H, Beck JC, Reuben DB (2002): Are there differencesbetween older persons who screen positive on the CAGE questionnaire and the ShortMichigan Alcoholism Screening Test – Geriatric Version? J Am Geriatr Soc 50(5):858–862.

Moos RH, Schutte K, Brennan P, Moos BS (2004): Ten-year patterns of alcohol consump-tionand drinking problems among older women and men. Addiction 99: 829–838.

Moos RH, Brennan PL, Schutte KK, Moos BS (2005): Older adults’ health and changes inlate-life drinking patterns. Aging Ment Health 9(1): 49–59.

Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Valli�res A (2004): Ran-domized clinical trial of supervised tapering and cognitive behavior therapy to facilitatebenzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry161(2): 332–342.

Morin CM, B�langer L, Bastien C, Valli�res A (2005): Long-term outcome after disconti-nuation of benzodiazepines for insomnia: a survival analysis of relapse. Behav Res Ther43 (1): 1–14.

Moriyama Y, Muramatsu T, Kato M, Kashima H (2004): Repeated clinical episodes ofWernicke-Korsakoff syndrome. Aust N Z J Psychiatry 38: 653.

Mrazek M, Menges C, Steffes J, Thelen B, Erkwoh R (1999): Therapeutische Erfahrungenbeim alkoholbedingten Korsakow-Syndrom. Nervenarzt 70: 790–794.

Mukamal KJ, Ascherio A, Mittleman MA, Conigrave KM, Camargo CA jr., Kawachi I,Stampfer MJ, Willett WC, Rimm EB (2005): Alcohol and risk for ischemic stroke in men:the role of drinking patterns and usual beverage. Ann Intern Med 142: 11–19.

M�ller WE (1992): Klinische Pharmakologie von Psychopharmaka im hçheren Lebensalter.In: H�fner H, Hennerici M (Hrsg.): Psychische Krankheiten und Hirnfunktion im Alter.Stuttgart: Fischer. S. 171–185.

M�ller WE (1995): Benzodiazepin-Tranquilizer. In: Riederer P, Laux G, Pçldinger W(Hrsg.): Neuro-Psycho-Pharmaka. Bd. 2: Tranquilizer und Hypnotika. Wien: Springer.S. 23–41.

M�ller R, Zilker T (2009): Medikamenten-, Drogen- und Alkoholabh�ngigkeit. In: FçrstlH (Hrsg.): Demenzen in Theorie und Praxis. Heidelberg: Springer. 2. Aufl. S. 171–191.

Munaf MR, Tilling K, Ben-Shlomo Y (2009): Smoking status and body mass index: alongitudinal study. Nicotine Tob Res 11(6): 765–771.

Mundle G (2000): Geriatrische Patienten. In: Zernig G, Saria A, Kurz M, O’Malley SS(Hrsg.): Handbuch Alkoholismus. Universit�tsklinik f�r Psychiatrie Innsbruck.S. 163–176.

Munro CA, Saxton J, Butters MA (2001): Alcohol dementia: „cortical“ or „subcortical“dementia? Arch Clin Neuropsychol 16: 523–533.

Najavits LM, Lester KM (2008): Gender differences in cocaine dependence. Drug AlcoholDepend 97(1–2): 190–194.

Nakao M, Takeuchi T, Nomura K, Teramoto T, Yano E (2006): Clinical application ofparoxetine for tapering benzodiazepine use in non-major-depressive outpatients visitingan internal medicine clinic. Psychiatry Clin Neurosci 60(5): 605–610.

Neutel CI (1995): Risk of Traffic Accident Injury after a Prescription for a Benzodiazepine.Ann Epidemiol 5: 239–244.

27

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Neutel CI, Hirdes JP, Maxwell CJ, Patten SB (1996): New Evidence on Benzodiazepine Useand Falls: the Time Factor. Age Ageing 25: 273–278.

Ngandu T, Helkala EL, Soininen H, Winblad B, Tuomilehto J, Nissinen A, Kivipelto M(2007): Alcohol drinking and cognitive functions: findings from the Cardiovascular RiskFactors Aging and Dementia (CAIDE) Study. Dement Geriatr Cogn Disord 23(3):140–149.

Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR (2006):Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partialagonist: results from a 7-week, randomized, placebo- and bupropion-controlled trialwith 1-year follow-up. Arch Intern Med 166(15): 1561–1568.

Niejahr E (2007): Altersarmut. Die Zeit 3. 9. 2007. http://www.zeit.de/2007/36/Alters-armut – Zugriff 30. 04. 2010.

Niveau G, Rougemont AL, La Harpe R (2002): Methadone maintenance treatment, cri-minality and overdose-related deaths. An ecological study, 1983–1999. Eur J PublicHealth 12(3): 224–227.

Nixon K (2006): Alcohol and adult neurogenesis: roles in neurodegenration and recovery inchronic alcoholism. Hippocampus 16: 287–295.

Nogueira AM, Pomp�ia S, Galdurz JC, Bueno OF (2006): Effects of a benzodiazepine onfree recall of semantically related words. Hum Psychopharmacol 21(5): 327–336.

Nordstrom BL, Kinnunen T, Utman CH, Garvey AJ (1999): Long-term effects of nicotinegum on weight gain after smoking cessation. Nicotine Tob Res 1(3): 259–268.

Norris KC, Thornhill-Joynes M, Robinson C, Strickland T, Alperson BL, Witana SC, WardHJ (2001): Cocaine use, hypertension, and end-stage renal disease. Am J Kidney Dis38(3): 523–528.

Nçthen M, Bçhm K (2009): Krankheitskosten in Deutschland: Welchen Preis hat dieGesundheit im Alter? In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit undKrankheit im Alter. Beitr�ge zur Gesundheitsberichterstattung des Bundes. Eine gemein-same Verçffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums f�rAltersfragen und des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 228–246.

Nystrçm C (2005): Effects of long-term benzodiazepine medication. A prospective cohortstudy: methodological and clinical aspects. Nord J Psychiatry 59(6): 492–497.

Oberwittler C (2006): Vitaminstoffwechselerkrankungen. In: G�nnewig T, Erbguth F(Hrsg.): Praktische Neurogeriatrie. Stuttgart: Kohlhammer. S. 386–398.

O’Carroll RE, Moffoot A, Ebmeier K, Goodwin GM (1994): Effects of fluvoxaminetreatment on cognitive functioning in the alcoholic Korsakoff syndrome. Psychopharma-cology 116: 85–88.

O’Hara P, Connett JE, Lee WW, Nides M, Murray R, Wise R (1998): Early and late weightgain following smoking cessation in the Lung Health Study. Am J Epidemiol 148(9):821–830.

Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K(2006): Efficacy and safety of the novel selective nicotinic acetylcholine receptor partialagonist, varenicline, for smoking cessation. Arch Intern Med 166(15): 1571–1577.

Opitz K (2000): Tabakabh�ngigkeit. Hilfen zum Entzug. In: Uchtenhagen A, Zieglg�ns-berger W (Hrsg.): Suchtmedizin. M�nchen: Urban & Fischer. S. 53–63.

Oscar-Berman M, Kirkley SM, Gansler DA, Couture A (2004): Comparisons of Korsakoffand non-Korsakoff alcoholics on neuropsychological tests of prefrontal brain functio-ning. Alcohol Clin Exp Res 28: 667–675.

Oslin D, Liberto JG, O’Brien J, Krois S, Norbeck J (1997): Naltrexone as an adjunctivetreatment for older patients with alcohol dependence. Am J Geriatr Psychiatry 5(4):324–332.

28

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Oslin DW, Slaymaker VJ, Blow FC, Owen PL, Colleran C (2005): Treatment outcomes foralcohol dependence among middle-aged and older adults. Addict Behav 30(7):1431–1436.

Oslin DW, Grantham S, Coakley E, Maxwell J, Miles K, Ware J, Blow FC, Krahn DD,Bartels SJ, Zubritsky C, Olsen E, Kirchner JE, Levkoff S (2006): PRISM-E: comparisonof integrated care and enhanced specialty referral in managing at-risk alcohol use. Psy-chiatr Serv 57(7): 954–958.

Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ; EURODEMIncidence Research Group (2004): Effect of smoking on global cognitive function innondemented elderly. Neurology 62(6): 920–924.

Oude Voshaar RC, Mol AJJ, Gorgels WJMJ, Breteler MHM, van Balkom AJLM, van deLisdonk EH, Kann CC, Zitman FG (2003c): Cross-Validation, Predictive Validity, andTime Course of the Benzodiazepine Dependence Self-Report Questionnaire in a Ben-zodiazepine Discontinuation Trial. Compr Psychiatry 44(3): 247–255.

Oude Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH,Breteler MH, Zitman FG (2006b): Predictors of long-term benzodiazepine abstinence inparticipants of a randomized controlled benzodiazepine withdrawal program. Can J Psy-chiatry 51 (7): 445–452.

Oude Voshaar RC, Gorgels WJ, Mol AJ, van Balkom AJ, Mulder J, van de Lisdonk EH,Breteler MH, Zitman FG (2006c): Long-term outcome of two forms of randomisedbenzodiazepine discontinuation. Br J Psychiatry 188: 188–189.

Oulis P, Konstantakopoulos G, Kouzoupis AV, Masdrakis VG, Karakatsanis NA, Karapou-lios E, Kontoangelos KA, Papadimitriou GN (2008a): Pregabalin in the discontinuationof long-term benzodiazepines’ use. Hum Psychopharmacol 23(4): 337–340.

Oulis P, Masdrakis VG, Karakatsanis NA, Karapoulios E, Kouzoupis AV, Konstantako-poulos G, Soldatos CR (2008b): Pregabalin in the discontinuation of long-term ben-zodiazepine use: a case-series. Int Clin Psychopharmacol 23(2): 110–112.

Owen-Smith V, Hannaford PC (1999): Stopping smoking and body weight in women livingin the United Kingdom. Br J Gen Pract 49(449): 989–990.

Pace-Schott EF, Morgan PT, Malison RT, Hart CL, Edgar C, Walker M, Stickgold R (2008):Cocaine users differ from normals on cognitive tasks which show poorer performanceduring drug abstinence. Am J Drug Alcohol Abuse 34(1): 109–121.

Pakesch G, Katschnig H, Dittrich R, Loimer N, Rasinger E, Tutsch G. (1993): Pr�valenzund soziodemographische Korrelate des Benzodiazepingebrauchs in einer Großstadt-bevçlkerung. Nervenarzt 64: 312–317.

Palmatier MI, Liu X, Caggiula AR, Donny EC, Sved AF (2007): The role of nicotinicacetylcholine receptors in the primary reinforcing and reinforcement-enhancing effectsof nicotine. Neuropsychopharmacology 32(5): 1098–1108.

Parkin T (2005): Das antike Griechenland und die rçmische Welt. Das Alter – Segen oderFluch? In: Thane P (Hrsg.): Das Alter. Eine Kulturgeschichte. Darmstadt: Primus/WBG.S. 31–70.

Parsons A, Aveyard P (2009): What is transtheoretical therapy? A response to Prochaska.Social Science & Medicine 68: 407–409.

Parsons AC, Shraim M, Inglis J, Aveyard P, Hajek P (2009): Interventions for preventingweight gain after smoking cessation. Cochrane Database Syst Rev Issue1. Art.No.:CD006219. DOI: 101002/14651858.CD006219.pub2.

Parsons A, Daley A, Begh R, Aveyard P (2010): Influence of smoking cessation afterdiagnosis of early stage lung cancer on prognosis: systemativ review of abservationalstudies with meta-analysis. BMJ 340:b5569. DOI: 101136/bmj.b5569.

29

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Paslakis G, Kiefer F, Diehl A, Alm B, Sobanski E (2010): Methylphenidat – Therapieoptionbei ADHS und Suchterkrankung im Erwachsenenalter? Nervenarzt 81(3): 277–288.

Paterniti S, Dufouil C, Alp�rovitch A (2002): Long-term benzodiazepine use and cognitivedecline in the elderly: the Epidemiology of Vascular Aging Study. J Clin Psychopharmacol22: 285–293.

Patkar AA, Vergare MJ, Batra V, Weinstein SP, Leone FT (2003): Tobacco smoking: currentconcepts in etiology and treatment. Psychiatry 66(3): 183–199.

Patterson TL, Jeste DV (1999): The potential impact of the baby-boom generation onsubstance abuse among elderly persons. Psychiatr Serv 50(9): 1184–1188.

Perkins KA (1993): Weight gain following smoking cessation. J Consult Clin Psychol 61(5):768–777.

Perneger TV, Klag MJ, Whelton PK (2001): Recreational drug use: a neglected risk factorfor end-stage renal disease. Am J Kidney Dis 38(1): 49–56.

Peter H, Penzel T, Peter JH (2007): Enzyklop�die der Schlafmedizin. Heidelberg: Springer.Peters M (2006): Psychosoziale Beratung und Psychotherapie im Alter. Gçttingen: Vanden-

hoeck & Ruprecht.Peters M, Kipp J (Hrsg.) (2002): Zwischen Abschied und Neubeginn. Entwicklungskrisen

im Alter. Gießen: Psychosozial.Peto R, Darby S, Deo H, Silcocks P, Whitley E, Doll R (2000): Smoking, smoking cessation,

and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321(7257): 323–329.

Petrovic M, Pevernagie D, Van Den Noortgate N, Mariman A, Michielsen W, Afschrift M(1999): A programme for short-term withdrawal from benzodiazepines in geriatric hos-pital inpatients: success rate and effect on subjective sleep quality. Int J Geriatr Psychiatry14 (9): 754–760.

Petrovic M, Pevernagie D, Mariman A, Van Maele G, Afschrift M (2002): Fast withdrawalfrom benzodiazepines in geriatric inpatients: a randomised double-blind, placebo-con-trolled trial. Eur J Clin Pharmacol 57 (11): 759–764.

Pfefferbaum A, Sullivan EV (2005): Disruption of white matter microstructure by excessiveintracellular and extracellular fluid in alcoholism: evidence from diffusion tensor ima-ging. Neuropsychopharmacology 30: 423–432.

Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006a): Supratentorial profile of whitemicrostructurell integritiy in recovering alcoholic men and women. Biol Psychiatry 59:364–372.

Pfefferbaum A, Adalsteinsson E, Sullivan EV (2006b): Dysmorphology and microstructuraldegradation of the corpus callosum: interaction of age and alcoholism. Neurobiol Aging27: 994–1009.

Philipp M, Buller R (1986): Klassifikatorische Probleme von Mißbrauch und kçrperlicherAbh�ngigkeit bei Benzodiazepinen. In: Hippius H, Engel RR, Laakmann G (Hrsg.):Benzodiazepine. R�ckblick und Ausblick. Berlin: Springer. S. 234–241.

Piasecki TM, McCarthy DE, Fiore MC, Baker TB (2008): Alcohol consumption, smokingurge, and the reinforcing effects of cigarettes: an ecological study. Psychol Addict Behav22(2): 230–239.

Picciotto MR, Addy NA, Mineur YS, Brunzell DH (2008): It is not „either/or“: activationand desensitization of nicotinic acetylcholine receptors both contribute to behaviorsrelated to nicotine addiction and mood. Prog Neurobiol 84(4): 329–342.

Pierucci-Lagha A, Derouesne C (2003): Alcoholism and aging. 2. Alcoholic dementia oralcoholic cognitive impairment? Psychol Neuropsychiatr Vieil 1: 237–249.

Pinquart M, Sçrensen S (2003): Differences between caregivers and noncaregivers in psy-chological health and physical health: a meta-analysis. Psychol Aging 18(2): 250–267.

30

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB(2008): Assessing dimensions of nicotine dependence: an evaluation of the NicotineDependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Depen-dence Motives (WISDM). Nicotine Tob Res 10(6): 1009–1020.

Piper ME, Smith SS, Schlam TR, Fiore MC, Jorenby DE, Fraser D, Baker TB (2009): ARandomized Placebo-Controlled Clinical Trial of 5 Smoking Cessation Pharmacothera-pies. Arch Gen Psychiatry 66(11): 1253–1262.

Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, Diana M (2006): Impaireddecision-making in opiate-dependent subjects: effect of pharmacological therapies. DrugAlcohol Depend 83(2): 163–168.

Pirie PL, McBride CM, Hellerstedt W, Jeffery RW, Hatsukami D, Allen S, Lando H (1992):Smoking cessation in women concerned about weight. Am J Public Health 82(9):1238–1243.

Pisani MA, Murphy TE, Van Ness PH, Araujo KL, Inouye SK (2007): Characteristicsassociated with delirium in older patients in a medical intensive care unit. Arch InternMed 167(15): 1629–1634.

Pisinger C, Jorgensen T (2007): Weight concerns and smoking in a general population: theInter99 study. Prev Med 44(4): 283–289.

Poling J, Kosten TR, Sofuoglu M (2007): Treatment outcome predictors for cocaine depen-dence. Am J Drug Alcohol Abuse 33(2): 191–206.

Pollm�cher T, Wetter TC (2008): Schlafstçrungen. In: Holsboer F, Gr�nder G, Benkert O(Hrsg.): Handbuch der Psychopharmakotherapie. Heidelberg: Springer. S. 977–993.

Pomara N, Facelle TM, Roth AE, Willoughby LM, Greenblatt DJ, Sidtis JJ (2006): Dose-dependent retrograde facilitation of verbal memory in healthy elderly after acute orallorazepam administration. Psychopharmacology 185(4): 4874–4894.

Pomp�ia S, Lucchesi LM, Bueno OF, Manzano GM, Tufik S (2004): Zolpidem and memo-ry: a study using the process-dissociation procedure. Psychopharmacology 174(3):327–333.

Pope CA III, Burnett RT, Krewski D, Jerrett M, Shi Y, Calle EE, Thun MJ (2009): Cardio-vascular Mortality and Exposure to Airborne Fine Particulate Matter and CigaretteSmoke. Shape of the Exposure-Response Relationship. Circulation 120: 941–948.

Poser W (1987): Klinik der Medikamentenabh�ngigkeit. In: Kisker KP, Lauter H, MeyerJE, M�ller C, Strçmgren E (Hrsg.): Psychiatrie der Gegenwart, Bd. 3: Abh�ngigkeit undSucht. Berlin: Springer. 3. Aufl. S. 401–424.

Poser W et al. (1985): Pharmakologische und klinische Daten zum Problem der Benzodia-zepinabh�ngigkeit. In: Hippius H (Hrsg.): Buspiron-Workshop. Neue Entwicklungen derPharmakotherapie der Angst. Gr�felfing: Edition Materia Medica.

Poser W, Poser S, Piesiur-Strehlow B, Eva P (1986): Entzugssyndrome, Abh�ngigkeitsrisikound Intoxikation mit Benzodiazepinen. In: Borchard U, Haring C (Hrsg.): Nutzen undGefahren der Therapie mit Benzodiazepinen. Darmstadt: Steinkopff. S. 33–39.

Poser W, Eva-Condemarin P (1991): Entzugssymptome nach abruptem Absetzen langfristigeingenommener Antidepressiva: Rebound-Symptomatik? Abh�ngigkeit? In: Hippius H,Ortner M, R�ther E (Hrsg.): Psychiatrische Erkrankungen in der �rztlichen Praxis. Ber-lin: Springer. S. 12–16.

Poser W, Poser S (1996): Medikamente – Missbrauch und Abh�ngigkeit. Stuttgart: Thieme.Pçtschke-Langer M, Schulze A, Klein R (2005): Zusatzstoffe in Tabakprodukten – neue

Erkenntnisse oder altes Wissen? In: Batra A (Hrsg.): Tabakabh�ngigkeit. Wissenschaft-liche Grundlagen und Behandlung. Stuttgart: Kohlhammer. S. 64–80.

Power C, Boiss� L, Rourke S, Gill MJ (2009): NeuroAIDS: an evolving epidemic. CanJ Neurol Sci 36(3): 285–295.

31

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Preiser G (1982): Wein im Urteil der griechischen Antike. In: Vçlger G, von Welck K(Hrsg.): Rausch und Realit�t. Drogen im Kulturvergleich. Band 2. Reinbek: Rohwolt.S. 507–529.

Preti A (2007): New developments in the pharmacotherapy of cocaine abuse. Addict Biol12(2): 133–151.

Preuss UW, Soyka M (1997): Das Wernicke-Korsakow-Syndrom: Klinik, Pathophysiologieund therapeutische Ans�tze. Fortschr Neurol Psychiat 65: 413–420.

Preuss UW, Soyka M (2000): Die Behandlung von alkoholbedingten hirnorganischen Psy-chosyndromen – Pharmakotherapeutische und psychotherapeutische Ans�tze. In:Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G, W�chtler C (Hrsg.):Angst – Sucht – Anpassungsstçrungen im Alter. Schriftenreihe der Deutschen Gesellschaftf�r Gerontopsychiatrie und -psychotherapie, Bd. 1. Stuttgart: Kohlhammer. S. 294–300.

Prigerson HG, Desai RA, Rosenheck RA (2001): Older adult patients with both psychiatricand substance abuse disorders: prevalence and health service use. Psychiatr Q 72(1):1–18.

Prochaska JJ, Gill P, Hall SM (2004): Treatment of tobacco use in an inpatient psychiatricsetting. Psychiatr Serv 55(11): 1265–1270.

Prochaska JJ, Hall SM, Tsoh JY, Eisendrath S, Rossi JS, Redding CA, Rosen AB, MeisnerM, Humfleet GL, Gorecki JA (2008): Treating tobacco dependence in clinically de-pressed smokers: effect of smoking cessation on mental health functioning. Am J PublicHealth 98(3): 446–448.

Prochaska JO (2009): Flaws in the theory or flaws in the study: A commentary on „Theeffect of Transtheoretical Model based interventions on smoking cessation“. Social Sci-ence & Medicine 68: 404–406.

Prochaska JO, DiClemente CC (1992): Stages of change in the modification of problembehaviors. Prog Behav Modif 28: 183–218.

Prosser J, Cohen LJ, Steinfeld M, Eisenberg D, London ED, Galynker II (2006): Neuro-psychological functioning in opiate-dependent subjects receiving and following metha-done maintenance treatment. Drug Alcohol Depend 84(3): 240–247.

Psychiatrie-EnquÞte (1975): Bericht �ber die Lage der Psychiatrie in der BundesrepublikDeutschland. – Zur psychiatrischen und psychotherapeutisch/psychosomatischen Versor-gung der Bevçlkerung (Drucksache 7/4200). Bonn: Deutscher Bundestag.

Quevillon F, B�dard MA (2003): Benzodiaz�pines: consequ�nces sur le fonctionnementmn�sique des personnes �gees. Sante Ment Que 28(2): 23–41.

Radebold H (1997): Psychoanalyse und Altern. Zwei einander Fremde beginnen den Dia-log. In: Ders. (Hrsg.): Altern und Psychoanalyse. Gçttingen: Vandenhoeck & Ruprecht.S. 5–20.

Radebold H (Hrsg.) (2003): Kindheiten im II. Weltkrieg und ihre Folgen. Gießen: Psycho-sozial.

Radebold H, Schweizer R (1996): Der m�hselige Aufbruch. �ber Psychoanalyse im Alter.Frankfurt/M.: Fischer.

Radebold H, Heuft G, Fooken I (Hrsg.) (2006): Kindheiten im Zweiten Weltkrieg. Kriegs-erfahrungen und deren Folgen aus psychohistorischer Perspektive. M�nchen: Juventa.

Rajaratnam R, Sivesind D, Todman M, Roane D, Seewald R (2009): The aging methadonemaintenance patient: treatment adjustment, long-term success, and quality of life.J Opioid Manag 5(1): 27–37.

Rapeli P, Kivisaari R, Autti T, K�hkçnen S, Puuskari V, Jokela O, Kalska H (2006):Cognitive function during early abstinence from opioid dependence: a comparison toage, gender, and verbal intelligence matched controls. BMC Psychiatry 24(6): 9.

32

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Rapeli P, Fabritius C, Alho H, Salaspuro M, Wahlbeck K, Kalska H (2007): Methadone vs.buprenorphine/naloxone during early opioid substitution treatment: a naturalistic com-parison of cognitive performance relative to healthy controls. BMC Clin Pharmacol12(7): 5.

R�sky E, Stronegger WJ, Freidl W (1996): The relationship between body weight andpatterns of smoking in women and men. Int J Epidemiol 25(6): 1208–1212.

Rathod NH, Addenbrooke WM, Rosenbach AF (2005): Heroin dependence in an Englishtown: 33-year follow-up. Br J Psychiatry 187: 421–425.

Ray WA, Griffin MR, Schaffner W, Baugh DK, Melton LJ (1987): Psychotropic Drug Useand the Risk of Hip Fracture. N Engl J Med 316: 363–369.

Ray WA, Griffin MR, Downey W (1989): Benzodiazepines of Long and Short Eliminationand the Risk of Hip Fracture. JAMA 262: 3303–3307.

Raz N, Nagel IE (2007): Der Einfluss des Hirnalterungsprozesses auf die Kognition: EineIntegration struktureller und funktioneller Forschungsergebnisse. In: Brandtst�dter J,Lindenberger U (Hrsg.): Entwicklungspsychologie der Lebensspanne. Stuttgart: Kohl-hammer. S. 97–129.

Reboussin BA, Anthony JC (2006): Is there epidemiological evidence to support the ideathat a cocaine dependence syndrome emerges soon after onset of cocaine use? Neuro-psychopharmacology 31(9): 2055–2064.

Reder LM, Oates JM, Dickison D, Anderson JR, Gyula F, Quinlan JJ, Ferris JL, Dulik M,Jefferson BF (2007): Retrograde facilitation under midazolam: the role of general andspecific interference. Psychon Bull Rev 14(2): 261–269.

Reece AS (2007): Evidence of accelerated ageing in clinical drug addiction from immune,hepatic and metabolic biomarkers. Immun Ageing 24;4: 6.

Reeves S, Bench C, Howard R (2002): Ageing and the nigrostriatal dopaminergic system.Int J Geriatr Psychiatry 17(4): 359–370.

Reid MC, Van Ness PH, Hawkins KA, Towle V, Concato J, Guo Z (2006): Light tomoderate alcohol consumption is associated with better cognitive function among oldermale veterans receiving primary care. J Geriatr Psychiatry Neurol 19(2): 98–105.

Reimer C, Jurkat HB, M�ulen B, Stetter F (2001): Zur Problematik der Suchtgef�hrdungvon berufst�tigen Medizinern. Psychotherapeut 46: 376–385.

Reinert DF, Allen JP (2007): The alcohol use disorders identification test: an update ofresearch findings. Alcohol Clin Exp Res 31(2): 185–199.

Reiter S, Schatz M, Hehlmann R (2005): Alkohol und Blut. In: Singer MV, Teyssen S(Hrsg.): Alkohol und Alkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl.S. 410–421.

Reitz C, Luchsinger J, Tang MX, Mayeux R (2005): Effect of smoking and time on cogni-tive function in the elderly without dementia. Neurology 65(6): 870–875.

Reitz C, den Heijer T, van Duijn C, Hofman A, Breteler MM (2007): Relation betweensmoking and risk of dementia and Alzheimer disease: the Rotterdam Study. Neurology69(10): 998–1005.

Renteln-Kruse W von (Hrsg.) (2004): Medizin des Alterns und des alten Menschen. Darm-stadt: Steinkopff.

Rezkalla SH, Kloner RA (2007): Cocaine-induced acute myocardial infarction. Clin MedRes 5(3): 172–176.

Rice VH, Stead LF (2008): Nursing interventions for smoking cessation. Cochrane Data-base Syst Rev Issue 1. Art. No.: CD001188. DOI: 101002/14651858.CD001188.pub3.

Rich JB, Svoboda E, Brown GG (2006): Diazepam-induced prospective memory impair-ment and its relation to retrospective memory, attention, and arousal. Hum Psychophar-macol 21(2): 101–108.

33

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Richards M, Jarvis MJ, Thompson N, Wadsworth ME (2003): Cigarette smoking andcognitive decline in midlife: evidence from a prospective birth cohort study. Am J PublicHealth 93(6): 994–998.

Richter D, Venzke A, Settelmayer J, Reker T (2002): H�ufige Wiederaufnahmen sucht-kranker Patienten in die station�re psychiatrische Behandlung – „Heavy User“ oderchronisch Kranke? Psychiat Prax 29: 364–368.

Rickels K (1986): Diskussionsbeitrag. In: Hippius H, Engel RR, Laakmann G (Hrsg.):Benzodiazepine. R�ckblick und Ausblick. Berlin: Springer. S. 136–137.

Rickels K, Schweizer E, Case WG, Greenblatt DJ (1990): Long-term therapeutic use ofbenzodiazepines. I. Effects of abrupt discontinuation. Arch Gen Psychiatry 47: 899–907.

Rickels K, Garcia-Espana F, Mandos LA, Case GW (2008): Physician Withdrawal Check-list (PWC-20). J Clin Psychopharmacol 28(4): 447–451.

Ried LD, Johnson RE, Gettman DA (1998): Benzodiazepine Exposure and FunctionalStatus in Older People. J Am Geriatr Soc 46: 71–76.

Rigotti NA, Munafo MR, Stead LF (2007): Interventions for smoking cessation in hospi-talised patients. Cochrane Database Syst Rev Issue 3. Art. No.: CD001837. DOI:101002/14651858.CD001837.pub2.

Rigotti NA, Munafo MR, Stead LF (2008): Smoking cessation interventions for hospitali-zed smokers: a systematic review. Arch Intern Med 168(18): 1950–1960.

Ripamonti C, Fagnoni E, De Conno F (2004): Withdrawal Syndrome After Delayed Tra-madol Intake. Am J Psychiatry 161(12): 2326.

Ritter A, Cameron J (2006): A review of the efficacy and effectiveness of harm reductionstrategies for alcohol, tobacco and illicit drugs. Drug Alcohol Rev 25(6): 611–624.

Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, CollierAC, Evans SR, Ellis RJ (2007): The prevalence and incidence of neurocognitive impair-ment in the HAART era. AIDS 21(14): 1915–1921.

Robin C, Trieger N (2002): Paradoxical reactions to benzodiazepines in intravenous seda-tion: a report of 2 cases and review of the literature. Anesth Prog 49(4): 128–132.

Rodriguez VillamaÇan JC, Blanco CA, Sanchez Sanchez A, Carvajal A, Arias LM, Del PozoJG (2000): Withdrawal syndrome after longterm treatment with tramadol. Br J GenPract 50: 406.

Rodu B, Stegmayr B, Nasic S, Cole P, Asplund K (2004): The influence of smoking andsmokeless tobacco use on weight amongst men. J Intern Med 255(1): 102–107.

Rommelspacher H (1999): Amphetamine und Entaktogene. In: Gastpar M, Mann K,Rommelspacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme.S. 228–236.

Rose JE (2006): Nicotine and nonnicotine factors in cigarette addiction. Psychopharmaco-logy 184(3–4): 274–285.

Rosenbloom MJ, Sullivan EV, Pfefferbaum A (2003): Using magnetic resonance imagingand diffusion tenor imaging to asses brain damage in alcoholics. Alcohol Res Health 27:146–152.

Rosenmayr L (1983): Die sp�te Freiheit. Das Alter – ein St�ck bewusst gelebten Lebens.Berlin: Severin und Siedler.

Roser P, Vollenweider FX, Kawohl W (2010): Potential antipsychotic properties of centralcannabinoid (CB1) receptor antagonists. World J Biological Psychiatry 11(2): 208–219.

Rost WD (1992): Psychoanalyse des Alkoholismus. Theorie, Diagnostik, Behandlung.Stuttgart: Klett-Cotta.

Rothschild AJ (1992): Disinhibition, amnestic reactions, and other adverse reactions secon-dary to triazolam: a review of the literature. J Clin Psychiatry 53(Suppl): 69–79.

34

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Rourke SB, Grant I (1999): The interactive effects of age and length of abstinence on therecovery of neuropsychological functioning in chronic male alcoholics: a 2-year follow-up study. J Int Neuropsychol Soc 5: 234–246.

Rowe MA, McCrae CS, Campbell JM, Benito AP, Cheng J (2008): Sleep pattern differencesbetween older adult dementia caregivers and older adult noncaregivers using objectiveand subjective measures. J Clin Sleep Med 4(4): 362–369.

Rummans T, Davis LJ, Morse RM, Ivnik RJ (1993): Learning and Memory Impairment inOlder, Detoxified, Benzodiazepine-Dependent Patients. Mayo Clin Proc 68: 731–737.

Rumpf HJ, Bromisch B, Botzet M, Hill A, Hapke U, John U (1998): Epidemiologie desAlkoholmissbrauchs im hçheren Alter. In: Havemann-Reinecke U, Weyerer S, Fleisch-mann H (Hrsg.): Alkohol und Medikamente, Missbrauch und Abh�ngigkeit im Alter.Freiburg. Lambertus. S. 29–37.

Rustembegovic A, Kundurovic Z, Sapcanin A, Sofic E (2003): A placebo-controlled studyof memantine (Ebixa) in dementia of Wernicke-Korsakoff syndrome. Med Arh 57:149–150.

Ryynanen OP, Kivela SL, Honkanen R, Laippala P, Saano V (1993): Medications andChronic Diseases as Risk Factors for Falling Injuries in the Elderly. Scand J Soc Med21: 264–271.

Sachs-Ericsson N, Schmidt NB, Zvolensky MJ, Mitchell M, Collins N, Blazer DG (2009):Smoking cessation behavior in older adults by race and gender: the role of health pro-blems and psychological distress. Nicotine Tob Res 11(4): 433–443.

Saffier K, Colombo C, Brown D, Mundt MP, Fleming MF (2007): Addiction Severity Indexin a chronic pain sample receiving opioid therapy. J Subst Abuse Treat 33(3): 303–311.

Sahin HA, Gurvit ICH, Bilgic B, Hanagasi HA, Emre M (2002): Therapeutic effects of anacetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff’s disease.Clin Neuropharmacol 25: 16–20.

Sa as T, Gallarda T (2008): R�actions d’agressivit� sous benzodiaz�pines: une revue de lalitt�rature. Encephale 34(4): 330–336.

Salaspuro M (2000): Marker f�r Alkoholismus und alkoholassoziierte Organsch�den. In:Seitz HK, Lieber CS, Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoholismus –Alkoholbedingte Organsch�den. Heidelberg: Barth. 2. Aufl. S. 96–124.

Salive ME, Cornoni-Huntley J, LaCroix AZ, Ostfeld AM, Wallace RB, Hennekens CH(1992): Predictors of smoking cessation and relapse in older adults. Am J Public Health82(9): 1268–1271.

Salize HJ, Merkel S, Reinhard I, Twardella D, Mann K, Brenner H (2009): Cost-effectiveprimary care-based strategies to improve smoking cessation: more value for money. ArchIntern Med 169(3): 230–235.

Saß AK, Wurm S, Ziese T (2009): Inanspruchnahmeverhalten. In: Bçhm K, Tesch-RçmerC, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitr�ge zur Gesundheitsbericht-erstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes,des Deutschen Zentrums f�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin:RKI. S. 134–159.

Satre DD, Mertens J, Are�n PA, Weisner C (2003): Contrasting outcomes of older versusmiddle-aged and younger adult chemical dependency patients in a managed care pro-gram. J Stud Alcohol 64(4): 520–530.

Satre DD, Mertens JR, Are�n PA, Weisner C (2004): Five-year alcohol and drug treatmentoutcomes of older adults versus middle-aged and younger adults in a managed careprogram. Addiction 99(10): 1286–1297.

35

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Savi� MM, Obradovi� DI, Ugresi� ND, Bokonji� DR (2005): Memory effects of benzodia-zepines: memory stages and types versus binding-site subtypes. Neural Plast 12(4):289–298.

Saxton J, Munro CA, Butters MA, Schramke C, McNeil MA (2000): Alcohol, dementia,and Alzheimer’s disease: comparison of neuropsychological profiles. J Geriatr PsychiatryNeurol 13: 141–149.

Sch�ufele M, Weyerer S (1999): Psychopharmakagebrauch und Sturzh�ufigkeit bei Alten-und Pflegeheimbewohnern: Eine prospektive epidemiologische Studie in Mannheim.Euro J Ger 1: 124–131.

Sch�ufele M, Weyerer S, Hendlmeier I, Kçhler L (2009): Alkoholbezogene Stçrungen beiMenschen in Einrichtungen der station�ren Altenhilfe: eine bundesweite repr�sentativeStudie. Suchttherapie 55(5): 292–302.

Scherbaum N (1999): Grundprinzipien der Therapie. In: Gastpar M, Mann K, Rommel-spacher H (Hrsg.): Lehrbuch der Suchtkrankheiten. Stuttgart: Thieme. S. 94–103.

Scherbaum N (2007): Die Substitutionsbehandlung Opiatabh�ngiger. Nervenarzt 78:103–110.

Schlaepfer TE, Lancaster E, Heidbreder R, Strain EC, Kosel M, Fisch HU, Pearlson GD(2006): Decreased frontal white-matter volume in chronic substance abuse. Int J Neuro-psychopharmacol 9(2): 147–153.

Schmidbauer W (1997): Hilflose Helfer. �ber die seelische Problematik der helfendenBerufe. Reinbek: Rowohlt. �berarbeitete und erweiterte Neuausgabe.

Schmidt KS, Gallo JL, Ferri C, Giovannetti T, Sestito N, Libon DL, Schmidt PL (2005): Theneuropsychological profile of alcohol-related dementia suggests cortical and subcorticalpathology. Dement Geriatr Cogn Disord 20: 286–291.

Schmidt LG (2005): Biologische Marker des Alkoholismus und alkoholassoziierte Organ-sch�den. In: Singer MV, Teyssen S (Hrsg.): Alkohol und Alkoholfolgekrankheiten. Hei-delberg: Springer. 2. Aufl. S. 121–129.

Schmitt M, Re S (2004): Partnerschaft im Alter. In: Kruse A, Martin M (Hrsg.): Enzyklo-p�die der Gerontologie. Bern: Huber. S. 373–386.

Schmitz JM, Lindsay JA, Green CE, Herin DV, Stotts AL, Gerard Moeller F (2009): High-dose naltrexone therapy for cocaine-alcohol dependence. Am J Addict 18(5): 356–362.

Schofield I, Kerr S, Tolson D (2007): An exploration of the smoking-related health beliefsof older people with chronic obstructive pulmonary disease. J Clin Nurs 16(9):1726–1735.

Schonfeld L, Dupree LW (1995): Treatment Approaches for Older Problem Drinkers. IntJ Addict 30: 1819–1842.

Schutte KK, Moos RH, Brennan PL (2006): Predictors of untreated remission from late-lifedrinking problems. J Stud Alcohol 67(3): 354–362.

Schutte KK, Brennan PL, Moos RH (2009): Treated and untreated remission from problemdrinking in late life: post-remission functioning and health-related quality of life. DrugAlcohol Depend 99(1–3): 150–159.

Schwabe U, Paffrath D (Hrsg.) (2009): Arzneiverordnungsreport 2009 Berlin: Springer.Schweizer E, Case WG, Rickels K (1989): Benzodiazepine Dependence and Withdrawal in

Elderly Patients. Am J Psychiatry 146: 529–531.Schweizer E, Rickels K, Case WG, Greenblatt DJ (1990): Long-Term Therapeutic Use of

Benzodiazepines. II. Effects of Gradual Taper. Arch Gen Psychiatry 47: 908–915.Seitz HK, Osswald BR, Pçschl G (2000a): Alkohol und Alter. In: Seitz HK, Lieber CS,

Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoholismus – Alkoholbedingte Organ-sch�den. Heidelberg: Barth. 2. Aufl. S. 159–170.

36

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Seitz HK, Lieber CS, Simanowski UA (Hrsg.) (2000b): Handbuch Alkohol – Alkoholismus– Alkoholbedingte Organsch�den. Heidelberg: Barth. 2. Aufl.

Simon KC, van der Mei IA, Munger KL, Ponsonby A, Dickinson J, Dwyer T, Sundstrçm P,Ascherio A (2010): Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB1*1501 on multiple sclerosis risk. Neurology 74: 1365–1371.

Singer MV, Teyssen S (Hrsg.) (2005): Alkohol und Alkoholfolgekrankheiten. Heidelberg:Springer. 2. Aufl. S. 410–421.

Singer EJ, Valdes-Sueiras M, Commins D, Levine A (2010): Neurologic presentations ofAIDS. Neurol Clin 28(1): 253–275.

Sivolap YP (2005): The current state of S.S. Korsakov’s concept of alcoholic polyneuriticpsychosis. Neuroscience and Behavioral Physiology 35(9): 977–982.

Skeie I, Brekke M, Lindbaek M, Waal H (2008): Somatic health among heroin addictsbefore and during opioid maintenance treatment: a retrospective cohort study. BMCPublic Health 31(8): 43.

Skurtveit S, Furu K, Bramness JG, Tverdal A (2008): Benzodiazepine use in all alcoholconsumers predicts use of opioids in patients 20 years later – a follow-up study of 13390men and women aged 40–42 years. Pharmacoepidemiol Drug Saf 17(9): 926–933.

Sleath B, Thorpe J, Landerman LR, Doyle M, Clipp E (2005): African-American and whitecaregivers of older adults with dementia: differences in depressive symptomatology andpsychotropic drug use. J Am Geriatr Soc 53(3): 397–404.

Smith DM, Atkinson RM (1995): Alcoholism and dementia. Int J Addict 30: 1843–1869.Smith PF (2005): The safety of cannabinoids for the treatment of multiple sclerosis. Expert

Opin Drug Saf 4(3): 443–456.Snyder PJ, Werth J, Giordani B, Caveney AF, Feltner D, Maruff P (2005): A method for

determining the magnitude of change across different cognitive functions in clinicaltrials: the effects of acute administration of two different doses alprazolam. Hum Psycho-pharmacol 20(4): 263–273.

Solfrizzi V, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Baldassarre G, Sca-picchio P, Scafato E, Amodio M, Capurso A, Panza F; Italian Longitudinal Study onAging Working Group (2007): Alcohol consumption, mild cognitive impairment, andprogression to dementia. Neurology 68(21): 1790–1799.

Solty H, Crockford D, White WD, Currie S (2009): Cigarette smoking, nicotine dependen-ce, and motivation for smoking cessation in psychiatric inpatients. Can J Psychiatry54(1): 36–45.

Sorock GS, Shimkin EE (1988): Benzodiazepine Sedatives and the Risk of Falling in aCommunity-Dwelling Elderly Cohort. Arch Intern Med 148: 2441–2444.

Soumerai SB, Simoni-Wastila L, Singer C, Mah C, Gao X, Salzman C, Ross-Degnan D(2003): Lack of relationship between long-term use of benzodiazepines and escalation tohigh dosages. Psychiatr Serv 54(7): 1006–1011.

Soyka M (2000): Verwirrtheitssyndrome bei Alkoholabh�ngigkeit – Differentialdiagnoseund Therapie. In: Kretschmar C, Hirsch RD, Haupt M, Ihl R, Kortus R, Stoppe G,W�chtler C (Hrsg.): Angst-, Sucht- und Anpassungsstçrungen im Alter. Schriftenreiheder Deutschen Gesellschaft f�r Gerontopsychiatrie und -psychotherapie Bd. 1. Stuttgart:Kohlhammer. S. 285–294.

Soyka M (2005): Alkohol und Psychiatrie. In: Singer MV, Teyssen S (Hrsg.): Alkohol undAlkoholfolgekrankheiten. Heidelberg: Springer. 2. Aufl. S. 496–508.

Soyka M (2008): Drogen- und Medikamentenabh�ngigkeit. In: Mçller HJ, Laux G, Kapf-hammer HP (Hrsg.): Psychiatrie und Psychotherapie. Bd. 2. Heidelberg: Springer.3. Aufl. S. 187–241.

37

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Speckens AEM, Heeren TJ, Rooijmans HGM (1991): Alcohol abuse among elderly patientsin a general hospital as identified by the Munich Alcoholism Test. Acta Psychiatr Scand83: 460–462.

Spiegelhalder K, Perlis ML, Hajak G, Riemann D (2009): Schlafstçrungen. In: VorderholzerU, Hohagen F (Hrsg.): Therapie psychischer Stçrungen. State of the Art 2008/2009.M�nchen: Urban & Fischer. 4. Aufl. S. 307–320.

Spira AP, Edelstein BA (2006): Behavioral interventions for agitation in older adults withdementia: an evaluative review. Int Psychogeriatr 8(2): 195–225.

Stalnaker TA, Takahashi Y, Roesch MR, Schoenbaum G (2009): Neural substrates ofcognitive inflexibility after chronic cocaine exposure. Neuropharmacology 56(Suppl1): 63–72.

Stampfer MJ, Kang JH, Chen J, Cherry R, Grodstein F (2005): Effects of moderate alcoholconsumption on cognitive function in women. N Engl J Med 352: 245–253.

Stapleton JM, Eckardt MJ, Martin PR, Adinoff B, Roehrich L, Bone GA, Rubinow DR,Linnoila M, (1988): Treatment of alcholic organic brain syndrome with the serotoninereuptake inhibitor fluvoxamine: a preliminary study. Adv Alcohol Subst Abuse 7: 47–51.

Staudinger UM (2000): Viele Gr�nde sprechen dagegen und trotzdem f�hlen viele Men-schen sich wohl: Das Paradox des subjektiven Wohlbefindens. Psychol Rundschau 51:185–197.

Staudinger UM, Baumert J (2007): Bildung und Lernen jenseits der 50: Plastizit�t undRealit�t. In: Gruss P (Hrsg.): Die Zukunft des Alterns. M�nchen: Beck. S. 240–257.

Stead LF, Lancaster T (2007): Interventions to reduce harm from continued tobacco use.Cochrane Database Syst Rev Issue 3. Art. No.: CD005231. DOI: 101002/1465-1858.CD005231.pub2.

Stead LF, Perera R, Lancaster T (2007): A systematic review of interventions for smokerswho contact quitlines. Tob Control 16 (Suppl 1): i3–8.

Stead LF, Bergson G, Lancaster T (2008a): Physician advice for smoking cessation. Coch-rane Database Syst Rev Issue 2. Art. No.: CD000165. DOI: 101002/146518-58.CD000165.pub3.

Stead LF, Perera R, Bullen C, Mant D, Lancaster T (2008b): Nicotine replacement therapyfor smoking cessation. Cochrane Database Syst Rev Issue 1. Art. No.: CD000146. DOI:101002/14651858.CD000146.pub3.

Steffens DC, Skoog I, Norton MC, Hart AD, Tschanz JT, Plassman BL, Wyse BW, Welsh-Bohmer KA, Breitner JC (2000): Prevalence of depression and its treatment in an elderlypopulation: the Cache County study. Arch Gen Psychiatry 57(6): 601–607.

Stephens DN, Duka T (2008): Review. Cognitive and emotional consequences of bingedrinking: role of amygdala and prefrontal cortex. Philos Trans R Soc Lond B Biol Sci363(1507): 3169–3179.

Stephens R, Ling J, Heffernan TM, Heather N, Jones K (2008): A review of the literatureon the cognitive effects of alcohol hangover. Alcohol Alcohol 43(2): 163–170.

Stetter F (2000): Psychotherapie. In: Zernig G, Saria A, Kurz M, O’Malley SS (Hrsg.):Handbuch Alkoholismus. Universit�tsklinik f�r Psychiatrie Innsbruck. S. 99–142.

Stewart R, Niessen WJ, Broer J, Snijders TA, Haaijer-Ruskamp FM, Meyboom-De Jong B(2007): General Practitioners reduced benzodiazepine prescriptions in an interventionstudy: a multilevel application. J Clin Epidemiol 60(10): 1076–1084.

St John PD, Montgomery PR, Tyas SL (2009): Alcohol misuse, gender and depressivesymptoms in community-dwelling seniors. Int J Geriatr Psychiatry 24(4): 369–375.

Stçhr M (2005): Die Wahrheit �ber Anti-Aging. Frankfurt/M.: Eichborn.

38

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Stolle, Martin; Sack, Peter-Michael; Thomasius, Rainer (2009): Rauschtrinken im Kindes-und Jugendalter: Epidemiologie, Auswirkungen und Intervention. Dtsch Arztebl Int106(19): 323–328.

Stumpf W (2003): Wenn Junkies in die Jahre kommen. In: Seeberger B, Braun A (Hrsg.):Wie die anderen altern. Zur Lebenssituation alter Menschen am Rande der Gesellschaft.Frankfurt/M.: Mabuse. S. 143–147.

Stupp�ck CH, Whitworth AB, Stupp�ck PCC (2000): Alkoholentzugssyndrom. In: ZernigG, Saria A, Kurz M, O’Malley SS (Hrsg.): Handbuch Alkoholismus. Universit�tsklinikf�r Psychiatrie Innsbruck. S. 71–80.

Subkowski P (2000): Die psychoanalytische Sicht der Abh�ngigkeitserkrankungen. Psycho-therapeut 45: 253–266.

Subkowski P (2009): Perversion und Suchtentwicklung. In: Bilitza KW (Hrsg.): Psycho-therapie der Sucht. Psychoanalytische Beitr�ge zur Praxis. Gçttingen: Vandenhoeck &Ruprecht, 2. Aufl. S. 91–100.

Sullivan EV, Marsh L (2003): Hippocampal volume deficits in alcoholic Korsakoff’s syn-drome. Neurology 61: 1716–1719.

Sullivan EV, Pfefferbaum A (2005): Neurocircuity in alcoholism: a substrate of disruptionand repair. Psychopharmacology 180: 583–594.

Surendrakumar D, Dunn M, Roberts CJC (1992): Hospital Admission and the Start ofBenzodiazepine Use. Br Med J 304: 881.

Sweitzer MM, Donny EC, Dierker LC, Flory JD, Manuck SB (2008): Delay discountingand smoking: Association with the Fagerstrçm Test for Nicotine Dependence but notcigarettes smoked per day. Nicotine Tob Res 10(10): 1571–1575.

Tait RJ, Hulse GK, Waterreus A, Flicker L, Lautenschlager NT, Jamrozik K, Almeida OP(2006): Effectiveness of a smoking cessation intervention in older adults. Addiction102(1): 148–155.

Tait RJ, Hulse GK, Waterreus A, Flicker L, Lautenschlager NT, Jamrozik K, Almeida OP(2008): Two-Year Outcomes From a Cessation of Smoking Intervention in Older Adults.Journal of Smoking Cessation 3(2): 101–109. DOI 101375/jsc.3. 2. 101.

Tait RJ, Siru R (2009): Executive cognitive function and cessation of smoking among olderadults. Aging Health 5(1): 33–37.

Tassain V, Attal N, Fletcher D, Brasseur L, D�gieux P, Chauvin M, Bouhassira D (2003):Long term effects of oral sustained release morphine on neuropsychological performancein patients with chronic non-cancer pain. Pain 104(1–2): 389–400.

Tata PR, Rollings J, Collins M, Pickering A, Jacobson RR (1994): Lack of CognitiveRecovery Following Withdrawal From Long-Term Benzodiazepine Use. Psychol Med24: 203–213.

Taylor DH Jr, Hasselblad V, Henley SJ, Thun MJ, Sloan FA (2002): Benefits of smokingcessation for longevity. Am J Public Health 92(6): 990–996.

Tedstone D, Coyle K (2004): Cognitive impairments in sober alcoholics: performance onselective and divided attention tasks. Drug Alcohol Depend 75: 277–286.

Teising M (2000): Die Angst vor dem Pflegefall. Psychodynamische Betrachtungen. Wien,Facultas.

Termorshuizen F, Krol A, Prins M, van Ameijden EJ (2005): Long-term outcome of chronicdrug use: the Amsterdam Cohort Study among Drug Users. Am J Epidemiol 161(3):271–279.

Tesch-Rçmer C, Wurm S (2009): Lebenssituationen �lter werdender und alter Menschen inDeutschland. In: Bçhm K, Tesch-Rçmer C, Ziese T (Hrsg.): Gesundheit und Krankheitim Alter. Beitr�ge zur Gesundheitsberichterstattung des Bundes. Eine gemeinsame Ver-

39

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

çffentlichung des Statistischen Bundesamtes, des Deutschen Zentrums f�r Altersfragenund des Robert-Koch-Instituts (RKI). Berlin: RKI. S. 113–120.

Thomson AD, Cook CC, Guerrini I, Sheedy D, Harper C, Marshall EJ (2008): Wernicke’sencephalopathy: „plus ca change, plus c’est la meme chose“. Alcohol Alcohol 43(2):180–186.

Thun MJ, Colditz GA (1998): Invited Commentary on „Early and Late Weight Gainfollowing Smoking Cessation in the Lung Health Study“. Am J Epidemiol 148(9):831–832.

Tinetti ME, Speechley M, Ginter SF (1988): Risk Factors for Falls Among Elderly PersonsLiving in the Community. N Engl J Med 319: 1701–1707.

Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND(2007a): Widespread disruption in brain activation patterns to a working memory taskduring cocaine abstinence. Brain Res 1171: 83–92.

Tomasi D, Goldstein RZ, Telang F, Maloney T, Alia-Klein N, Caparelli EC, Volkow ND(2007b): Thalamo-cortical dysfunction in cocaine abusers: implications in attention andperception. Psychiatry Res 155(3): 189–201.

Tçnne U, Hiltunen AJ, Vikander B, Engelbrektsson K, Bergmann H, Bergman I, LeifmanH, Borg S (1995): Neuropsychological Changes During Steady-State Drug Use, With-drawal and Abstinence in Primary Benzodiazepine-Dependent Patients. Acta PsychiatrScand 91: 299–304.

Tonstad S (2009): Cigarette smoking, smoking cessation, and diabetes. Diabetes Res ClinPract 85(1): 4–13.

Trollor JN, Anderson TM, Sachdev PS, Brodaty H, Andrews G (2007): Prevalence ofmental disorders in the elderly: the Australian National Mental Health and Well-BeingSurvey. Am J Geriatr Psychiatry 15(6): 455–466.

Truelsen T, Thudium D, Gronbaek M, Copenhagen City Heart Study (2002): Amount andtype of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology 59:1313–1319.

Tsai MJ, Tsai YH, Huang YB (2007): Compulsive activity and anterograde amnesia afterzolpidem use. Clin Toxicol 45(2): 179–181.

Tsoh JY, Humfleet GL, MuÇoz RF, Reus VI, Hartz DT, Hall SM (2000): Development ofmajor depression after treatment for smoking cessation. Am J Psychiatry 157(3):368–374.

Tsunoda K, Uchida H, Suzuki T, Watanabe K, Yamashima T, Kashima H (2010): Effects ofdiscontinuing benzodiazepine-derivative hypnotics on postural sway and cognitivefunctions in the elderly. Int J Geriatr Psychiatry. DOI: 101002/gps. 2465.

Tverdal A, Bjartveit K (2006): Health consequences of reduced daily cigarette consump-tion. Tob Control 15(6): 472–480.

Twardella D, K�pper-Nybelen J, Rothenbacher D, Hahmann H, W�sten B, Brenner H(2004): Short-term benefit of smoking cessation in patients with coronary heart disease:estimates based on self-reported smoking data and serum cotinine measurements. EurHeart J 25(23): 2101–2108.

Twardella D, Brenner H (2005): Lack of training as a central barrier to the promotion ofsmoking cessation: a survey among general practitioners in Germany. Eur J Public Health15(2): 140–145.

Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H (2006a): Thediagnosis of a smoking-related disease is a prominent trigger for smoking cessation in aretrospective cohort study. J Clin Epidemiol 59(1): 82–89.

40

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H (2006b): Theimpact of body weight on smoking cessation in German adults. Preventive Medicine 42:109–113.

Twardella D, Rothenbacher D, Hahmann H, W�sten B, Brenner H (2006c): The Underes-timated Impact of Smoking and Smoking Cessation on the Risk of Secondary Cardio-vascular Disease Events in Patients With Stable Coronary Heart Disease: ProspectiveCohort Study. JACC 4: 884–892.

Twardella D, Brenner H (2007): Effects of practitioner education, practitioner payment andreimbursement of patients’ drug costs on smoking cessation in primary care: a clusterrandomised trial. Tob Control 16(1): 15–21.

Tyrer P, Murphy S, Riley P (1990): The Benzodiazepine Withdrawal Symptom Question-naire. J Affect Disord 19(1): 53–61.

Tyrer P (1993b): Pharmacological differences in the dependence potential of benzodiaze-pines. In: Hallstrçm C (Ed.): Benzodiazepine Dependence. Oxford: Oxford Univ. Press.S. 221–237.

Uchtenhagen A, Zieglg�nsberger W (Hrsg.) (2000): Suchtmedizin. Konzepte, Strategienund therapeutisches Management. M�nchen: Urban & Fischer.

Ullmann R (2010): Substanzabh�ngigkeit und ADHS bei Erwachsenen. Suchttherapie 11:6–7.

Unal B, Critchley J, Capewell S (2003): Impact of smoking reduction on coronary heartdisease mortality trends during 1981–2000 in England and Wales. Tob Induc Dis 1(3):185.

Valenstein M, Taylor KK, Austin K, Kales HC, McCarthy JF, Blow FC (2004): Benzodia-zepine use among depressed patients treated in mental health settings. Am J Psychiatry161(4): 654–661.

Vanable PA, King AC, de Wit H (2000): Psychometrische Erfassungsinstrumente. In: Zer-nig G, Saria A, Kurz M, O’Malley SS (Hrsg.): Handbuch Alkoholismus. Universit�ts-klinik f�r Psychiatrie Innsbruck. S. 41–52.

Vandivort R, Teich JL, Cowell AJ, Chen H (2009): Utilization of substance abuse treatmentservices under Medicare, 2001–2002. J Subst Abuse Treat 36(4): 414–419.

van Hulten R, Bart Teeuw K, Bakker A, Leufkens HG (2003): Initial 3-month usagecharacteristics predict long-term use of benzodiazepines: an 8-year follow-up. Eur J ClinPharmacol 58: 689–694.

van Vliet P, van der Mast RC, van den Broek M, Westendorp RGJ, de Craen AJM (2009):Use of benzodiazepines, depressive symptoms and cognitive function in old age. IntJ Geriatr Psychiatry 24: 500–508.

Vaupel JW, von Kistowski KG (2007): Die Plastizit�t menschlicher Lebenserwartung undihre Konsequenzen. In: Gruss P (Hrsg.): Die Zukunft des Alterns. M�nchen: Beck.S. 51–78.

Verdejo A, Toribio I, Orozco C, Puente KL, P�rez-Garc�a M (2005): Neuropsychologicalfunctioning in methadone maintenance patients versus abstinent heroin abusers. DrugAlcohol Depend 78(3): 28328–28328.

Verster JC, Volkerts E (2004): Clinical pharmacology, clinical efficacy, and behavioraltoxicity of alprazolam: a review of the literature. CNS Drug Rev 10(1): 45–76.

Verwey B, Muntendam A, Ensing K, Essink G, Pasker-de Jong PC, Willekens FL, ZitmanFG (2005): Clinically relevant anterograde amnesia and its relationship with blood levelsof benzodiazepines in suicide attempters who took an overdose. Prog Neuropsychophar-macol Biol Psychiatry 29(1): 47–53.

Victor M (1994): Alcoholic dementia. Can J Neurol Sci 21: 88–99.

41

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Vogt I (2009b): �ltere Drogenabh�ngige in vier europ�ischen L�ndern und ihr Hilfebedarf(SDDCARE), Zwischenergebnisse. Vortrag bei der Fachtagung „�ltere Drogenabh�ngige– Versorgungskonzepte an der Schnittstelle zwischen Sucht- und Altenhilfe“ am 22. Ok-tober 2009 in M�nchen. http://www.paritaet-bayern.de/webcode/link.php?id=954 –Zugriff 30. 04. 2010.

Vogt I (Hrsg.) (2011): Auch Drogenabh�ngige altern. Frankfurt: Fachhochschul-Verlag (imDruck).

Vçlger G, von Welck K (Hrsg.) (1982): Rausch und Realit�t. Drogen im Kulturvergleich.Drei B�nde. Reinbek: Rohwolt.

Volkow ND, Wang GJ, Fowler JS, Telang F (2008): Overlapping neuronal circuits inaddiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B BiolSci 363(1507): 3191–3200.

Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J,Lerman C (2006): A randomized controlled trial of financial incentives for smokingcessation. Cancer Epidemiol Biomarkers Prev 15(1): 12–18.

von Ferber L, Ihle P, Kçster I, Krappweis J (1992): Abh�ngigkeit im Spiegel der Verwal-tungsdaten einer Ortskrankenkasse aus dem Jahre 1983 unter besonderer Ber�cksichti-gung der Abh�ngigkeit bei �rztlich verordneten Medikamenten. In: Deutschen Haupt-stelle gegen die Suchtgefahren (Hrsg.): Medikamentenabh�ngigkeit. Freiburg:Lambertus. S. 43–58.

von Kondratowitz HJ von (1999): Sozialanthropologie. In: Jansen B, Karl F, Radebold H,Schmitz-Scherzer R (Hrsg.): Soziale Gerontologie. Weinheim: Beltz. S. 106–125.

Vorderholzer U, Hohagen F (1998): Schlafstçrungen und Hypnotikagebrauch im hçherenLebensalter. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol undMedikamente, Missbrauch und Abh�ngigkeit im Alter. Freiburg: Lambertus. S. 73–85.

Vorma H, Naukkarinen H, Sarna S, Kuoppasalmi K (2003): Long-term outcome afterbenzodiazepine withdrawal treatment in subjects with complicated dependence. DrugAlcohol Depend 70: 309–314.

Vupputuri S, Batuman V, Muntner P, Bazzano LA, Lefante JJ, Whelton PK, He J (2004):The risk for mild kidney function decline associated with illicit drug use among hyper-tensive men. Am J Kidney Dis 43(4): 629–35.

Wadsworth EJ, Moss SC, Simpson SA, Smith AP (2005): Psychotropic medication use andaccidents, injuries and cognitive failures. Hum Psychopharmacol 20(6): 391–400.

Waern M (2003): Alcohol dependence and misuse in elderly suicides. Alcohol Alcohol38(3): 249–254.

Wahl WW, Tesch-Rçmer C (Hrsg.) (2000): Angewandte Gerontologie in Schl�sselbegriffen.Stuttgart: Kohlhammer.

Wahl WW, Heyl V (2004): Gerontologie – Einf�hrung und Geschichte. Stuttgart: Kohl-hammer.

Walther E (1982): Kulturhistorisch-ethnologischer Abriss �ber den Gebrauch von Tabak.In: Vçlger G, von Welck K (Hrsg.): Rausch und Realit�t. Drogen im Kulturvergleich.Band 1. Reinbek: Rohwolt. S. 374–386.

Wang D, Connock M, Barton P, Fry-Smith A, Aveyard P, Moore D (2008): Cut down toquit’ with nicotine replacement therapies in smoking cessation: a systematic review ofeffectiveness and economic analysis. Health Technol Assess 12(2): iii–iv, ix–xi, 1–135.

Warner EA, Greene GS, Buchsbaum MS, Cooper DS, Robinson BE (1998): Diabetic keto-acidosis associated with cocaine use. Arch Intern Med 158(16): 1799–1802.

Weakland JH, Herr JJ (1988): Beratung �lterer Menschen und ihrer Familien. Bern: Huber.2. Aufl.

42

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Weeß HG, Steiberg R, Pritzel M (1994): Kognitive Nebenwirkungen bei Langzeit high-doseDiazepam-Mißbrauch. In: Mayer G (Hrsg.): Jahrbuch Schlafmedizin in Deutschland1994. M�nchen: MMV. S. 77–80.

Weih M, Wiltfang J (2006): Demenz – Grundlagen. In: Oswald WD, Lehr U, Sieber C,Kornhuber J (Hrsg.): Gerontologie. Stuttgart: Kohlhammer, 3. Aufl. S. 132–138.

West R (2005): Time for a change: putting the Transtheoretical (Stages of Change) Modelto rest. Addiction 100: 1036–1039.

Wetterling T, Driessen M, Kanitz RD, Junghanns K (2001): The severity of alcohol with-drawal is not age dependent. Alcohol Alcohol 36(1): 75–78.

Wetterling T, Kugler C (2005): �ltere Suchtkranke im psychiatrischen Krankenhaus. ZGerontopsychol psychiatr 19(4): 195–200.

Weyerer S (1993): Die psychopharmakologische Behandlung �lterer Menschen in der All-gemeinbevçlkerung und in Heimen: Epidemiologische Befunde. Sucht 39: 180–186.

Weyerer S, Sch�ufele M, Zimber A (1998): Epidemiologie des Psychopharmakagebrauchsim hçheren Alter. In: Havemann-Reinecke U, Weyerer S, Fleischmann H (Hrsg.): Alkoholund Medikamente, Missbrauch und Abh�ngigkeit im Alter. Freiburg: Lambertus.S. 38–49.

Weyerer S, Sch�ufele M, Hendlmeier I (2006): Alkoholmissbrauch und -abh�ngigkeit beiBewohnern und Bewohnerinnen in Altenpflegeheimen: Repr�sentative Ergebnisse aus derStadt Mannheim. Z Gerontopsychol psychiatr 19 (4): 297–236.

Weyerer S, Sch�ufele M, Eifflaender-Gorfer S, Kçhler L, Maier W, Haller F, Cvetanovska-Pllashiniku G, Pentzek M, Fuchs A, van den Bussche H, Zimmermann T, Eisele M, BickelH, Mçsch E, Wiese B, Angermeyer MC, Riedel-Heller SG; for the German AgeCoDeStudy group (2009): At-risk alcohol drinking in primary care patients aged 75 years andolder. Int J Geriatric Psychiatry. 24(12):1376–85

Whitson HE, Heflin MT, Burchett BM (2006): Patterns and predictors of smoking cessa-tion in an elderly cohort. J Am Geriatr Soc 54(3): 466–471.

WHO – World Health Organization (2005): Internationale Klassifikation der Funktions-f�higkeit, Behinderung und Gesundheit. Kçln: Deutsches Institut f�r Medizinische Doku-mentation und Information (DIMDI). http://www.dimdi.de/dynamic/de/klassi/down-loadcenter/icf/endfassung/icf_endfassung-2005-10-01.pdf – Zugriff 30. 04. 2010.

WIdO – Wissenschaftliches Institut der AOK (2009): Arzneiverbrauch nach Arztgruppen2008. Verordnungen, Ums�tze, definierte Tagesdosen aufgegliedert nach Arztgruppen.Berlin: WIdO.

Wilhelm J, Bayerlein K, Hillemacher T, Reulbach U, Frieling H, Kromolan B, Degner D,Kornhuber J, Bleich S (2006): Short-term cognition deficits during early alcohol with-drawal are associated with elevated plasma homocysteine levels in patients with alcohol-ism. J Neural Trans 113: 357–363.

Wilson KC, Copeland JR, Taylor S, Donoghue J, McCracken CF (1999): Natural history ofpharmacotherapy of older depressed community residents. The MRC-ALPHA Study. Br JPsychiatry 175: 439–443.

Wise RA, Enright PL, Connett JE, Anthonisen NR, Kanner RE, Lindgren P, O’Hara P,Owens GR, Rand CS, Tashkin DP (1998): Effect of weight gain on pulmonary functionafter smoking cessation in the Lung Health Study. Am J Respir Crit Care Med 157(3 Pt1): 866–872.

Witt R (1998): Therapie mit abh�ngigen Senioren in der Fachklinik. In: Havemann-Rein-ecke U, Weyerer S, Fleischmann H (Hrsg.): Alkohol und Medikamente, Missbrauch undAbh�ngigkeit im Alter. Freiburg: Lambertus. S. 136–141.

43

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Woicik PA, Moeller SJ, Alia-Klein N, Maloney T, Lukasik TM, Yeliosof O, Wang GJ,Volkow ND, Goldstein RZ (2009): The neuropsychology of cocaine addiction: recentcocaine use masks impairment. Neuropsychopharmacology 34(5): 1112–1122.

Wojnar M, Wasilewski D, Zmigrodzka I, Grobel I (2001): Age-related differences in thecourse of alcohol withdrawal in hospitalized patients. Alcohol Alcohol 36(6): 577–583.

Wolf R, Grohmann B, Mçssner B, Poser W, R�ther E, Schmidt LG (1994): Medikamenten-missbrauch und Abh�ngigkeit. In: Grohmann R, E. R�ther E, Schmidt LG (Hrsg.):Unerw�nschte Wirkungen von Psychopharmaka. Ergebnisse der AM�P-Studie. Berlin:Springer. S. 278–308.

Wçlfling K, B�hler M, Lem�nager T, Mçrsen C, Mann K (2009): Gl�cksspiel- und Inter-netsucht. Nervenarzt 80(9): 1030–1039.

Wolffgramm J, Heyne A (2005): Ratten als Langzeitkonsumenten von Nikotin: Der Wegzur Nikotinsucht. In: Batra A (Hrsg.): Tabakabh�ngigkeit. Wissenschaftliche Grundlagenund Behandlung. Stuttgart: Kohlhammer. S. 30–41.

Wolter DK (2004): Gerontopsychiatrische Tageskliniken. In: Eikelmann B, Reker T (Hrsg.):Psychiatrie und Psychotherapie in der Tagesklinik. Stuttgart. Kohlhammer. S. 83–96.

Wolter DK (2006): Alkohol-assoziierte kognitive Beeintr�chtigungen – ein Kontinuum vonsubklinischer Leistungsminderung bis zur schweren Demenz? Z Gerontopsychol psychi-atr 19(4): 207–220.

Wolter DK (2010): Schlaf- und Beruhigungsmittel im Alter. Psychopharmakotherapie17(1): 39–46.

Wolter-Henseler DK: (1996): Zur Problematik der Benzodiazepinverordnung im Alter.Psycho 22: 454–464.

Wolters EC, van der Werf YD, van den Heuvel OA (2008): Parkinson’s disease-relateddisorders in the impulsive-compulsive spectrum. J Neurol 255(Suppl 5): 48–56.

Won A, Lapane KI, Vallow S, Schein J, Morris JN, Lipsitz LA (2006): Long term effects ofanalgesics in a population of elderly nursing home residents with persistent nonmalig-nant pain. J Gerontol A Biol Sci Med Sci 61(2): 165–169.

Wood-Mitchell A, James IA, Waterworth A, Swann A, Ballard C (2008): Factors influen-cing the prescribing of medications by old age psychiatrists for behavioural and psycho-logical symptoms of dementia: a qualitative study. Age Ageing 37(5): 547–552.

Woods SP, Moore DJ, Weber E, Grant I (2009): Cognitive neuropsychology of HIV-asso-ciated neurocognitive disorders. Neuropsychol Rev 19(2): 152–168.

Wright CB, Elkind MS, Rundek T, Boden-Albala B, Paik MC, Sacco RL (2006a): Alcoholintake, carotid plaque, and cognition: The Northern Manhattan Study. Stroke 37:1160–1164.

Wright CB, Elkind MS, Luo X, Paik MC, Sacco RL (2006b): Reported alcohol consump-tion and cognitive decline: The northern Manhattan study. Neuroepidemiology 27(4):201–207.

Wu P, Wilson K, Dimoulas P, Mills EJ (2006): Effectiveness of smoking cessation therapies:a systematic review and meta-analysis. BMC Public Health 11;6: 300.

W�bbels R (1989): Suchterkrankungen im Pflegeheim. In: Hamburgische Landesstellegegen die Suchtgefahren (Hrsg.): Abh�ngigkeit im Alter. Mçglichkeiten und Grenzender Hilfe. Hamburg. S. 31–35.

Wurm S, Lampert T, Menning S (2009a): Subjektive Gesundheit. In: Bçhm K, Tesch-RçmerC, Ziese T (Hrsg.): Gesundheit und Krankheit im Alter. Beitr�ge zur Gesundheitsbericht-erstattung des Bundes. Eine gemeinsame Verçffentlichung des Statistischen Bundesamtes,des Deutschen Zentrums f�r Altersfragen und des Robert-Koch-Instituts (RKI). Berlin:RKI. S. 79–91.

44

Literatur

© 2

010

W. K

ohlh

amm

er, S

tuttg

art

Wurm S, Engstler H, Tesch-Rçmer C (2009b): Ruhestand und Gesundheit. In: Kochsiek K(Hrsg.): Altern und Gesundheit. (Altern in Deutschland Band 7). Nova Acta LeopoldinaNF 105, Nr. 369: 81–192. Halle (Saale): Deutsche Akademie der Naturforscher Leo-poldina/Stuttgart: Wissenschaftliche Verlagsgesellschaft.

Wurst FM, Seidl S, Alt A (2000): �thylglukuronid – der direkte �thanolmetabolit, seineBedeutung als Alkoholkonsum- und R�ckfallmarker, Nachweismethoden und Perspek-tiven. In: Seitz HK, Lieber CS, Simanowski UA (Hrsg.): Handbuch Alkohol – Alkoho-lismus – Alkoholbedingte Organsch�den. Heidelberg: Barth. 2. Aufl. S. 125–129.

Yang JC, Huang D, Hser YI (2006): Long-term morbidity and mortality among a sample ofcocaine-dependent black and white veterans. J Urban Health 83(5): 926–940.

Yates WR, Nguyen MH, Warnock JK (2001): Tramadol dependence with no history ofsubstance abuse. Am J Psychiatry 158(6): 964.

Zanjani F, Mavandadi S, TenHave T, Katz I, Durai NB, Krahn D, Llorente M, Kirchner J,Olsen E, Van Stone W, Cooley S, Oslin DW (2008): Longitudinal course of substancetreatment benefits in older male veteran at-risk drinkers. J Gerontol A Biol Sci Med Sci63(1): 98–106.

Zank S, Peters M, Wilz G (2010): Klinische Psychologie und Psychotherapie des Alters.Stuttgart: Kohlhammer.

Zeyfang, Hagg-Gr�n, Nikolaus (2008): Basiswissen Medizin des Alterns und des altenMenschen. Berlin: Springer.

Zieglg�nsberger W, Hçllt V (2000): Opiate und Opiode. In: Uchtenhagen A, Zieglg�ns-berger W (Hrsg.): Suchtmedizin. M�nchen: Urban & Fischer. S. 87–97.

Zitman FG, Couv�e JE (2001): Chronic benzodiazepine use in general practice patientswith depression: an evaluation of controlled treatment and taper-off. Report on behalf ofthe Dutch Chronic Benzodiazepine Working Group. Br J Psychiatry 178: 317–324 (auchin: Couv�e JA: Towards a treatment of chronic benzodiazepine users suffering fromdepression. Dissertation Universit�t Leiden. S. 19–34).

Zutt J (1958): Zur Anthropologie der Sucht. Nervenarzt 29(10): 439–445.

45

Dirk K. Wolter: Sucht im Alter – Altern und Sucht

© 2

010

W. K

ohlh

amm

er, S

tuttg

art